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Abstract 
Agrin and neuregulin are neurotrophic molecules well known for their roles at 
synapses in the peripheral and central nervous systems. The expression of these two 
molecules is not restricted to these sites however, as they are broadly expressed across 
multiple organ systems.  What roles do agrin and neuregulin play within these alternate 
systems; what is the function of these molecules outside the nervous system?   Here I 
investigate potential roles for agrin and neuregulin in inflammation. Inflammation is an 
immediate response by innate immune cells, primarily macrophages, to infection and is 
characterized by the synthesis of pro-inflammatory mediators. The innate immune system 
possesses multiple redundant mechanisms to locally control inflammation. The neuro-
immune axis is one means of control.  Often called the cholinergic anti-inflammatory 
pathway, it acts to regulate local inflammation via nerve-secreted acetylcholine signaling 
through the homopentameric !7 nicotinic acetylcholine receptors (!7nAChR) present on 
macrophages. 
 Both agrin and neuregulin have been independently described to share an intricate 
relationship with acetylcholine receptors (AChR) in the nervous system. Agrin is best known 
for its role in AChR aggregation at the neuromuscular junction while neuregulin has related 
roles in AChR transcription, cell survival, communication and differentiation. Based on the 
common characteristics of synapses in the nervous and immune systems we were curious to 
see if agrin and neuregulin played analogous roles on macrophages.  
Here we show that agrin and its receptor dystroglycan are expressed on RAW264.7 
macrophages. In addition, agrin treated macrophages demonstrate increased endogenous 
agrin and !7nAChR expression. By blocking !-dystroglycan (!-DG), a receptor for agrin, 
with an anti-!-DG antibody we further saw a reduction in agrin expression. We also show 
that agrin is able to aggregate surface !7nAChRs and transmembrane agrin co-localizes with 
!7nAChRs therein. Agrin appears to induce approximately a 15-fold increase in anti-
inflammatory cytokine IL-10 in macrophages but does not increase pro-inflammatory 
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cytokine TNF-! or IL-6 synthesis. Agrin-treated macrophages challenged with LPS, a potent 
activator of inflammation, exhibit a 57% decrease in IL-6. Macrophages treated with agrin 
also exhibit a 4-fold increase in STAT3, a regulator of anti-inflammatory action.  
 The potential anti-inflammatory effects of agrin in the periphery parallel previous 
work describing the effects of neuregulin in the brain. Previous work completed by our lab 
suggests a role for neuregulin in augmenting the expression of !7nAChRs on microglia, the 
macrophages of the brain, but not in peripheral macrophages. Here we show that treatment of 
LPS challenged microglia with neuregulin produces an 88% decrease in IL-6 and a 33% 
decrease in TNF-!. These results indicate both agrin and neuregulin are able to induce an 
increase in !7nAChRs and augment the synthesis of pro- and anti-inflammatory cytokines in 
their respective systems. These results also further the support the evidence of neuro-immune 
crosstalk in the immune system. Taken together these results present two novel players in 
inflammatory regulation by macrophages in the periphery and CNS. 
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Chapter 1 
Introduction 
1.1 General introduction 
The word synapse is derived from the Greek root ‘sunaptein’ meaning to fasten together 
(Yamada and Nelson, 2007). Synapse formation, also called synaptogenesis, is pivotal for 
cell-to-cell communication and is typically dependent on the clustering and activation of 
surface receptors and the establishment of efficient signal transduction. Traditionally the 
study of synapses involved neurons and the membrane-to-membrane junctions they formed 
with other neurons or target cells. However, a more modern interpretation of synapses has 
them defined as a point of cell-cell contact or interaction between a variety of cells and tissue 
types. A modern synapse is thus a stable connection or junction that forms between 
homologous or heterologous cells for cell-to-cell communication (Dustin and Colman, 2002). 
Most synapses can be categorized into electrical or chemical synapses, and are distinguished 
by their mode of transmitting signals. Electrical synapses, those that communicate via gap 
junctions, are found in a minority of neuronal synapses and typically only in the mammalian 
inferior olivary nucleus, neocortex, hippocampus and thalamus (Eccles, 1982; Bennett, 1997; 
Connors and Long, 2004). The vast majority of neuronal synapses then are chemical synapses 
and cell-to-cell communication is via chemical intermediaries such as neurotransmitters.  
 Synapses found outside of the nervous system are similar to those within and are 
characterized by stable adhesions, the secretion of chemical factors, as well as the clustering 
of various pre-synaptic and post-synaptic molecules. The formation of a functional synapse is 
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reliant on multiple factors that regulate, organize and reorganize membrane proteins, lipids 
and receptors at the site of cellular contact. This process is mediated in a sequential manner 
by a number of proteins, and is essential for effective and efficient cell-cell signalling 
(Reviewed in Yamada and Nelson, 2007). Synapses can form between a variety of cell and 
tissue types, including motor neurons and muscle (termed a neuromuscular junction (NMJ) 
or post-synaptic apparatus), between neurons (interneuronal synapses), and between immune 
cells (immune synapses) (Figure 1). Though these synapses are extrinsically different due to 
the cells involved, structurally and functionally they are intrinsically similar in that they 
contain stable contacts mediated by cellular adhesion molecules allowing cell-cell 
communication to be achieved by the secretion of chemical mediators that then bind to their 
specific receptors.  
Agrin and neuregulin are two molecules with very prominent roles in synapse 
formation. They share a number of common functions and signaling mechanisms in both the 
peripheral and central nervous systems and appear cooperative in processes mediating 
acetylcholine receptor (AChR) clustering, stability, density and regulation (Hoch, 1999).  
AChRs are ubiquitously expressed across many tissues and cells where they have 
been implicated in a variety of regulatory roles. Of particular importance to this thesis is the 
expression of AChRs on endothelial and immune cells, such as macrophages. AChRs on 
these cells have been described to be a central part of a neuro-immune axis, termed the 
cholinergic anti-inflammatory pathway, crucial for regulating inflammation.  
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From an evolutionary standpoint, one might expect the conservation of molecules and 
mechanisms throughout synaptic contacts in a variety of tissues. Given their pivotal role in 
the formation and maintenance of synapses within the nervous system, agrin and neuregulin 
are likely key players in cell-to-cell contacts fitting our more modern, broader definition of a 
synapse. Based on the close relationship between the organizing molecules of neural 
synaptogenesis with AChRs, and the abundance of AChRs in non-neural tissues, the study of 
these molecules and their expression and roles in other tissues, becomes very attractive. Here 
I introduce agrin and neuregulin, including their intricate relationship with AChRs, and 
investigate their potential roles in modulating inflammation and the cholinergic anti-
inflammatory pathway. 
 
1.2 Agrin 
1.2.1 Agrin organizes synapses 
The protein agrin is a highly glycosylated heparin sulfate proteoglycan that is broadly 
expressed as multiple isoforms in the basement membranes and on cell surfaces in a number 
of tissues (Tsen et al., 1995a). Agrin, from the Greek word ‘agrein’ meaning to assemble, 
was originally named for its notable ability to aggregate AChRs (Nitkin, 1987). Though 
originally isolated in the electric organ of Torpedo californica (Nitkin, 1987; Smith et al., 
1987), agrin has been extensively described at the mammalian NMJ where it plays a pivotal 
role in synapse formation (Rupp et al., 1992; Fallon and Hall, 1994; Gautam et al., 1996) by 
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regulating cell-cell interactions (Cole and Halfter, 1996). Synapse formation at the NMJ is 
primarily characterized by the aggregation and stabilization of AChRs (Reviewed in Sanes 
and Lichtman, 1999 and Kummer et al., 2006), an essential process required for efficient 
nerve-myofibre communication and ultimately muscle function.  
The core agrin protein is approximately 200kDa but when glycosylated this protein 
can reach a molecular weight of up to 600kDa (Tsen et al., 1995a). It is composed of multiple 
domains and has a linear sequence of ~1900 amino acids (Rupp et al., 1991). Agrin can be 
divided into 4 domains (Figure 2) (Reviewed in Iozzo, 1998). Domain I is a globular domain 
identified as N-terminal agrin (NtA) that binds laminin and thus becomes immobilized in 
basal laminas (Denzer et al., 1997). Domain II is composed of nine follistatin-like repeats 
each containing protease inhibitor type domains, a cystine/proline-rich domain and a laminin 
III domain (Rupp et al., 1991). It also contains N-glycosylation sites and glycosaminoglycan 
(GAG) attachment sites.  Domain III contains a central SEA motif, serine/threonine-rich 
domains, GAG attachment sites and is highly glycosylated (Rupp et al., 1991). The final 
region, domain IV, contains a serine/threonine-rich domain, four epidermal growth factor 
(EGF)-like repeats, four laminin-like G domains, and three splice sites X, Y and Z (Rupp et 
al., 1991; Ferns et al., 1992). It is within this final region that the laminin-like G domains 
confer agrin’s binding to its receptors. Thus, the majority of the C-terminal half of agrin is 
particularly important for binding (laminin-like G domains) and clustering activity (Bowe et 
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al., 1994; Campanelli et al., 1994; Gee et al., 1994; Sugiyama et al., 1994; Gesemann et al., 
1996). 
  
1.2.2 Alternative splicing mediates agrin function 
Alternative mRNA splicing at several sites within the agrin transcript produces a number of 
agrin protein isoforms. These events occur at one site in the N-terminus and three sites, the 
X, Y and Z sites, in the C-teriminus. The agrin gene contains two different promoters that 
allow for tissue-specific regulation and can produce two isoforms that differ in their N-
termini: the short-N-terminus (SN) and the long-N-terminus (LN). These two isoforms differ 
by a sequence of 49 (SN) or 150 amino acids (LN) (Burgess et al., 2000; Neumann et al., 
2001). SN-agrin gives rise to transmembrane agrin (Tm-agrin), which is highly expressed in 
the central nervous system (CNS), and is potentially involved in cell adhesion processes 
(Tsen et al., 1995b).  Tm-agrin does not contain NtA, does not bind laminin and can induce 
AChR clustering, however it does not appear to play a role in NMJ formation (Neumann et 
al., 2001). LN-agrin contains the NtA domain and signal peptide and is essential to synapse 
formation at the NMJ. Furthermore, LN-agrin is preferentially expressed in non-neuronal 
cells and neurons that innervate non-neuronal cells such as motor neurons (Stetefeld et al., 
2001). 
Further agrin heterogeneity is generated through alternative splicing at its C-terminal 
end (Ferns et al., 1992) with these isoforms differing greatly in function (Campanelli et al., 
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1996). Agrin’s ability to aggregate AChRs (Ferns et al., 1992; 1993; Campanelli et al., 1996) 
as well as its ability to bind its receptors (Gesemann et al., 1996) is dependent on splicing at 
the Y and Z sites (Figure 2).  The isoform expressed by muscle, muscle agrin, has either a 
four amino acid insert at the Y site or no inserts at the Y and Z sites. Muscle agrin exhibits 
low AChR clustering capabilities even at high concentrations (Godfrey, 1991; Lieth et al., 
1992; Rüegg et al., 1992; Hoch et al., 1993). In motor neurons, the inclusion of an eight 
amino acid insert at the Z position produces neural agrin (Ferns et al., 1992). It is this 
isoform, neural agrin, that is responsible for agrin’s activity at the NMJ (Reist et al., 1992). 
Splicing at this position does not appear to occur in peripheral tissues outside of the nervous 
system (Khan et al., 2001) and the function of these broadly expressed non-neural agrin 
isoforms is unclear. 
Neural agrin, facilitates the clustering of AChRs on muscle through a complex 
signaling pathway that results in the redistribution of AChRs, re-organization of the actin 
cytoskeleton (Sanes and Lichtman, 1999), and increased transcription of AChR subunits 
(Jones et al., 1996). Agrin appears to have numerous binding partners on muscle or within 
the basal lamina surrounding muscle, including integrins, heparin, and laminins (Reviewed in 
Sanes et al., 1998).  Two, however, are of particular interest, low-density lipoprotein-related 
protein 4 (LRP4; Kim et al., 2008; Zhang et al., 2008) and dystroglycan (DG; Campanelli et 
al., 1994; Gee et al., 1994; Sealock and Froehner, 1994) and their role in mediating agrin 
function will be discussed below. 
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1.2.3 The Agrin-MuSK signaling pathway mediates AChR clustering 
Agrin activity is mediated by a heterodimeric receptor complex comprised of a muscle-
specific receptor tyrosine kinase, a co-receptor and a cytosolic peripheral membrane protein. 
Muscle-specific kinase (MuSK), LRP4 and rapsyn, are central to AChR aggregation and are 
necessary for synapse formation at the NMJ. Overexpression of any of these components 
results in the clustering of AChRs and knockout (KO) experiments in mice targeting any of 
these three proteins result in impaired synapse development, and impaired nerve-induced 
AChR aggregation. The strongest phenotype was observed in MuSK KO mice, which 
exhibited no AChR aggregates (DeChiara et al., 1996). Moreover, MuSK KO mice are 
unresponsive to agrin, suggesting that it is MuSK that functions as the agrin receptor.  
On myotubes, MuSK is rapidly phosphotyrosylated in response to agrin treatment. 
However, if MuSK alone is transfected into fibroblasts it does not become phosphorylated 
when treated with agrin indicating that MuSK must function through another component, 
perhaps a co-receptor (Glass et al., 1996). This unknown muscle specific co-receptor was 
termed MASC (for Myotube-Associated Specific Component) and was not identified until 
fairly recently as LRP4 (Kim et al., 2008; Zhang et al., 2008). Finally, rapsyn, originally 
called the 43 kd post-synaptic protein, or 43K, is highly concentrated in the electric organ of 
Torpedo californica and mammalian vertebrate NMJs (Porter and Froehner, 1983) and 
interacts with AChRs (Burden et al., 1983). KO experiments targeting rapsyn, a cytoplasmic 
peripheral membrane protein that colocalizes to AChRs, exhibit defective NMJs. These 
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indicated that rapsyn is also necessary for AChR aggregation (Gautam et al., 1996). The 
interactions of a variety of other agrin-associated molecules are described below.  
Agrin secreted by the nerve terminal binds to the MuSK co-receptor LRP4, initiating 
a trans-phosphorylation event that results in AChR aggregation and cytoskeleton re-
organization (Kim et al., 2008; Zhang et al., 2008). MuSK signaling is crucial for AChR 
aggregation events in the developing synapse (Glass et al., 1996)( Figure 3). Phosphorylation 
of MuSK leads to the recruitment of the adaptor proteins tumourous imaginal disc (Tid1; 
Linnoila et al., 2008), downstream-of-kinase or docking protein 7 (Dok7; Bergamin et al., 
2010), rapsyn  (Apel et al., 1997; Glass and Yancopoulos, 1997), dishevelled (Dvl) and p21-
activated kinase (PAK; Luo et al., 2002). The role of these adaptor proteins and how they 
function with respect to MuSK activation are described below.  
Dok7 is a cytoplasmic adaptor protein originally referred to as p62 (Yamanashi and 
Baltimore, 1997). Dok7 KO mice exhibit a similar phenotype to MuSK and Agrin KO mice 
and as a result appear to be essential for NMJ formation (Okada, 2006). Dok7 binding to 
MuSK is regulated by Tid1 (Linnoila et al., 2008) which is required for MuSK activation 
(Okada, 2006) and facilitates trans-phosphorylation events (Bergamin et al., 2010). Tid1 is a 
mammalian homolog of Drosophila tumor suppressor and heat-shock protein 40 (hsp40) and 
can partially activate MuSK in the absence of agrin. This allows the binding and dimerization 
of Dok7 (Linnoila et al., 2008). Tid1 also regulates the activity of the GTPases Rac1, RhoA, 
and cdc42 in an agrin-dependent manner which regulate AChR clustering and mediates 
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AChR phosphorylation (Linnoila et al., 2008). Tyrosine phosphorylated AChRs demonstrate 
an enhanced association with the cytoskeleton (Borges, 2001) via an agrin-induced increase 
in rapsyn (Moransard et al., 2003). Tid1 is part of the hsp40 family and binds to hsp70 
(Linnoila et al., 2008), which interacts with rapsyn via hsp90" (Luo et al., 2008). Hsp90" 
thus regulates rapsyn turnover and maintains the stability of rapsyn associated with AChRs 
(Luo et al., 2008). In addition to AChRs and hsp90", rapsyn also interacts with "-catenin/!-
catenin which is also linked to the cytoskeleton (Zhang et al., 2007) and stabilizes AChRs by 
inhibiting calpain activity in a calcium-dependent manner (Chen et al., 2007). This supports 
early findings that indicated that agrin mediates AChR clustering in a calcium-dependent 
manner (Megeath and Fallon, 1998; Megeath et al., 2003).  Therefore, agrin-MuSK signaling 
is heavily reliant upon the function of Tid1 and its associated molecules, through which 
stability and clustering can be achieved. 
Another MuSK binding partner, Dvl was originally discovered in Drosophila where it 
is involved in the development of arrays of polarized cells (Perrimon and Mahowald, 1987). 
It appears that Dvl and PAK also mediate agrin-induced AChR clustering via activated Rho 
GTPases Rac1 and cdc42 signaling mediated by Dvl bound to MuSK and PAK (Weston et 
al., 2000; Luo et al., 2002). This mechanism is not unlike the Wnt pathways which have also 
been implicated in NMJ development (Reviewed in Henríquez and Salinas, 2012). In 
particular Wnt3 and agrin activate complementary pathways that activate the Rac and Rho 
GTPases, respectively, both of which, as described earlier, mediate AChR phosphorylation 
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and clustering (Henríquez et al., 2008). Adenomatous polypsis coli (APC), a known effector 
of Wnt signaling, is also associated with AChRs and appears necessary for clustering and the 
regulation "-catenin stability (Wang et al., 2003b). Though a variety of molecules have been 
implicated in complementing the clustering of AChRs through association with MuSK, it is 
evident that this process is complex and converges upon only a few common signaling 
mediators, namely Rac and cdc42. 
Interestingly, ACh and agrin appear to have antagonistic effects at synapses. ACh 
secreted by the nerve terminal binds to the AChRs present on muscle inducing activity. 
Cholinergic signaling stimulates an increase in calpain activity which activates cyclin-
dependent kinase 5 (Cdk5; Chen et al., 2007) destabilizing AChR clusters (Lin et al., 2005). 
In contrast it appears that agrin signaling enhances the association of rapsyn with calpain, 
decreasing its activity and thus inhibiting AChR cluster dispersal (Chen et al., 2007).  
  
1.2.4 Agrin also signals through DG complexes 
DGs are dystrophin-associated glycoproteins (DAGs) that are highly concentrated at NMJs 
(Ohlendieck et al., 1991) and have been implicated in synapse formation (Reviewed in 
Winder, 2001 and Pilgram et al., 2010). DGs are composed of !-DG, a peripheral membrane 
protein that is associated non-covalently with "-DG, an integral membrane protein, both of 
which are the product of the post-translational cleavage of a single transcript (Ibraghimov-
Beskrovnaya et al., 1992; Henry and Campbell, 1996). DGs are a component of a dystrophin-
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associated protein complex (DAPC) and are necessary for the stabilization and condensation 
of AChRs at the NMJ through their interaction with the underlying cytoskeleton and 
overlying extracellular matrix (ECM; Ervasti and Campbell, 1991; Carbonetto et al., 1999; 
Jacobson et al., 2001) (Figure 4). DG is an integral part of the DAPC and is absent in the 
muscle of Duchene’s muscular dystrophy (Ervasti et al., 1990) . Agrin binds to !-DG with 
high affinity (Bowe et al., 1994; Campanelli et al., 1994; Gee et al., 1994) however the agrin 
domain necessary for this binding is not necessary for agrin-MuSK signaling (Meier et al., 
1996; Jacobson et al., 1998). As such it does not appear to be a co-receptor with MuSK 
(Jacobson et al., 1998) or by extension with LRP4. However further studies have 
demonstrated undeniably that DG is important in the process of AChR aggregation (Jacobson 
et al., 1998; Kahl and Campanelli, 2003) though the exact mechanism is still unclear.  
DG reportedly has extracellular mechanisms of regulating aspects of AChR clustering 
primarily through !-DG and functions to mediate the size and density of AChR clusters 
(Jacobson et al., 2001). Cells deficient in !-DG exhibit a decrease in AChR clusters 
(Jacobson et al., 1998) perhaps due to the intact juxtamembrane of "-DG, which appears to 
inhibit agrin activity (Kahl and Campanelli, 2003). Thus it is likely that agrin signaling 
through "-DG which modulates AChR clustering (Kahl and Campanelli, 2003) 
DG also colocalizes with major key players in synapse formation including MuSK, 
agrin and AChRs. MuSK, AChRs and DGs are linked together by rapsyn, which is regulated 
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by agrin (Moransard et al., 2003), reinforcing the importance of DG in agrin-mediated 
signaling and AChR stability (Apel et al., 1995). 
 Curiously, biglycan may provide another link between DG and agrin-MuSK 
signaling.  Biglycan is able to bind both !-DG (Bowe et al., 2000) and MuSK, potentially 
regulating agrin-induced MuSK phosphorylation. Consistent with this, biglycan-null mice 
exhibit a decrease in MuSK expression and in the stability of AChR clusters (Amenta et al., 
2012). Biglycan, however, does not appear necessary for the development of synapses and 
pre-patterning but is prominent at mature synapses (Amenta et al., 2012) which suggests that 
DG may function downstream of agrin signaling.  
DG signaling is also able to influence AChR aggregation via an agrin-MuSK 
independent pathway (Montanaro et al., 1998).  The extracellular domain of DG is capable of 
targeting laminin to AChRs (Tremblay, 2006). Laminin is an ECM protein capable of 
binding DG and stimulating AChR clustering independent of the agrin-MuSK pathway 
(Montanaro et al., 1998), and functions downstream of agrin and rapsyn by coordinating the 
assembly of NMJs (Jacobson et al., 2001).  
Although DG plays a crucial role in synapse stability, there has been some debate 
over whether it can function as a phosphorylatable receptor. "-DG contains a PPxY site in its 
C-terminus, which is a conserved tryptophan (WW) binding motif (Sotgia et al., 2001). It 
would appear that DG expressed in muscle is not detectably phosphorylated, likely due to the 
fact that this site is obstructed by another protein, either dystrophin or the dystrophin 
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homolog utrophin, which associates with the cytoskeleton and the PPxY site (Russo et al., 
2000). However, DG expression is not limited to muscle and it is possible that in other 
tissues it is fully capable of being phosphorylated. Experiments completed in Chinese 
hamster ovary (CHO) cells, wherein a full-length construct of the "-DG molecule was 
expressed, demonstrated that the PPxY site can be phosphotyrosylated by Src and this may 
act as a regulatory switch for proteins that can bind this site such as growth factor receptor-
bound protein (Grb2; Sotgia et al., 2001). Grb2 is an adaptor protein important in linking the 
ECM to signal transduction pathways leading to cytoskeletal reorganization and has been 
demonstrated to co-immunoprecipitate with DG in muscle and brain (Yang et al., 1995). 
Previous studies have shown that in non-muscle cells tyrosine phosphorylation of "-DG 
recruits and directly mediates association with Grb2 (Cavaldesi et al., 1999). Grb2 functions 
upstream of Raf-MEK-ERK of the mitogen-activated protein kinase pathway (MAPK; 
(Spence et al., 2004). DG has also been implicated in directly interacting with components of 
the ERK-MAPK signaling cascade, specifically mitogen-activated protein kinase kinase 
(MEK; (Spence et al., 2004), as well as indirectly with the phosphatidylinisitol-3 kinase 
(PI3K)-Akt signaling cascade (Xiong et al., 2009), important in cytoskeleton reorganization 
and cell survival, respectively. These interactions with DG may also be important for 
pathway cross-talk via MAPK in the agrin-MuSK pathway or the neuregulin signaling 
pathway (see Neuregulin below, section 1.3) in various tissues and perhaps other signaling 
pathways that activate MAPK and control a range of cellular processes (Spence et al., 2004; 
Rimer, 2011).  
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1.2.5 The role of agrin is not well understood in the CNS 
Agrin appears to be principally involved in synaptogenesis in the CNS, though it also has 
roles in plasticity, axonal growth and more interestingly, the establishment of the blood brain 
barrier (BBB; Reviewed in Daniels, 2012). Agrin is broadly expressed in a variety of 
neuronal synapses and its expression is highly concentrated at interneuronal synapses (Mann 
and Kröger, 1996; Hilgenberg, 2002; Kröger and Schröder, 2002; Hilgenberg et al., 2006). 
However, at these sites it is the transmembrane form of agrin that is predominantly expressed 
in the CNS (Burgess et al., 2000; Neumann et al., 2001).  Unlike at the NMJ, the formation of 
interneuronal synapses is not solely dependent on agrin (Gingras and Ferns, 2001). Secreted 
agrin does, nonetheless, appears to be involved in the formation and maintenance of a subset 
of excitatory synapses in the mouse brain, including those that are cholinergic (Gingras and 
Ferns, 2001; Ksiazek et al., 2007).  
 MuSK, the agrin co-receptor, has been shown to be expressed at interneuronal 
synapses though its role in synapse formation here is unclear (Garcia-Osta et al., 2006).  
LRP4, another potential agrin receptor, is expressed in synaptic regions of the brain and has 
been shown to co-localize with post-synaptic density 95 (PSD-95; a protein functionally 
similar to rapsyn) but direct interaction with agrin has yet to be reported (Tian et al., 2006). 
One study suggests that it is agrin acting through MuSK, however, those results pointed 
toward a role in cortical synapse stability and maintenance (Ksiazek et al., 2007), even 
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though MuSK has been heretofore implicated in learning and synaptic plasticity through the 
activation of the cAMP response element binding (CREB) pathway (Garcia-Osta et al., 
2006).  Signaling through the !3 subunit of a Na+ K+ ATPase (!3NKA) channel, a functional 
neuronal receptor for agrin in the CNS, leads to the induction of CREB as well and enhances 
the signaling at excitatory synapses (Ji et al., 1998; Hilgenberg et al., 1999) . The regulation 
of CREB through neural agrin modulates membrane potential and has been associated with 
memory formation and synaptic plasticity (Ji et al., 1998).  
Endogenously expressed Tm-agrin may also play a role in influencing synapse 
formation in the CNS through the regulation of dendritic filopodia (McCroskery et al., 2006; 
2009). Tm-agrin clustering positively regulates filopodia, which are known to promote 
synapse formation. The mechanism by which Tm-agrin achieves this is not well understood 
though it has been shown to be dependent on the activation of Rac and cdc42 via the 
adhesive effect mediated by the GAG chains on agrin (McCroskery et al., 2006; Lin et al., 
2010). Additionally, Tm-agrin’s association with lipid rafts results in the subsequent 
activation of signaling pathways involving proto-oncogene tyrosine-protein kinase (Fyn) and 
MAPK (Ramseger et al., 2009). As such, it has been proposed that Tm-agrin itself may act as 
a receptor or co-receptor that initiates these processes (Annies et al., 2006; Ramseger et al., 
2009). Recent evidence has also demonstrated that Tm-agrin signaling through !3NKA is 
responsible for the differentiation and survival of interneurons in the olfactory bulb of the 
brain (Burk et al., 2012). Therefore, MuSK and !3NKA appear to function independently but 
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co-operatively to activate the CREB pathway and Tm-agrin can potentially function as a 
receptor through its GAG chains to mediate agrin’s effects in the brain.   
 
 
1.3 Neuregulin 
The neuregulin (NRG) family of genes is composed of 4 members: NRG1, NRG2, NRG3 and 
NRG4. However, unless otherwise specified the term “NRG” or “neuregulin” in this thesis 
will be in reference to NRG1 derived proteins.  The remaining three genes do not, as of this 
writing, play a significant role in these systems.  NRGs, as they are now all called, were 
initially isolated from a variety of tissues by multiple labs. As a result multiple proteins from 
the same gene bore names reflecting differing functions. These include: heregulin (HRG; 
(Holmes et al., 1992) or neu differentiation factor (NDF; (Peles et al., 1992; Wen et al., 
1992), acetylcholine receptor-inducing activity (ARIA; (Falls et al., 1993), glial growth 
factor 2 (GGF2; (Goodearl et al., 1993; Marchionni et al., 1993) and sensory and motor 
neuron-derived factor (SMDF; (Ho et al., 1995). These names indicate the variety of roles 
that NRGs has been found to be involved in which is the result of alternative splicing.  
 
1.3.1 Alternative splicing of Neuregulin results in many isoforms  
There are many NRG1 isoforms (at least 16 structurally distinct proteins), which result from 
multiple promoters and alternative splicing (Meyer et al., 1997). NRGs are characterized by 
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their EGF-like domain and N-terminal sequence. The conserved EGF-like domain (! or ") is 
used to activate receptors and common to all isoforms. The N-terminal sequence (Type I, II, 
III) is differentiated by an immunoglobulin-like domain or a cysteine-rich domain. Type I 
NRGs contain an extracellular, immunoglobulin-like domain. Type II NRGs contain the 
previously mentioned domain in addition to a kringle domain. Type III NRGs contain a 
cysteine-rich domain. Only NRGs containing the immunoglobulin-like domain (Type I and 
II) are cleaved to become secreted forms, while Type III remains a membrane-bound protein. 
These NRGs differ not only in structure but also in function.  
 
1.3.2 Neuregulin is originally described as the inducer of post-synaptic 
proteins 
Of particular interest to this thesis is ARIA, a Type I NRG and 42 kDa glycoprotein, first 
isolated from chick brain. Here ARIA was found to not only aggregate AChRs but also 
increase the expression of the !-subunit of AChRs in chick myotubes (Usdin and Fischbach, 
1986; Harris et al., 1988; Falls et al., 1990; Chu et al., 1995; Jo et al., 1995). ARIA was also 
found to increase !-, $- and %-subunit AChR mRNA levels 2-fold and &-subunits up to 10-
fold in mouse myotubes (Martinou et al., 1991). ARIA has been demonstrated to induce the 
phosphorylation of a 185 kDa tyrosine kinase receptor protein (Corfas et al., 1993; Falls et 
al., 1993) related to epidermal growth factor receptor (EGFR; Holmes et al., 1992; 
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Marchionni et al., 1993).  This receptor was later described as being part of the erbB family 
of receptors (Reviewed in Fischbach and Rosen, 1997). 
 
1.3.3 Neuregulin signals through the erbB family of receptors 
NRGs bind to their receptors via the EGF-like domain (Meyer et al., 1997) and are the 
functional ligands for the EGF-receptor erbB family of tyrosine kinases (Reviewed in Yarden 
and Sliwkowski, 2001). The erbB family is comprised of four proteins: EGFR, erbB2, erbB3 
and erbB4 of which only the last three are expressed in skeletal muscle (Zhu et al., 1995). 
NRG binding to erbB induces the formation of a functional erbB hetero- and/or homodimers 
and binds with a specific affinity for erbB3 or erbB4 (Carraway and Cantley, 1994). This 
results in the tyrosine phosphorylation of erbB2 heterodimers or erbB4 homo- and/or 
heterodimers; erbB3 appears to have little tyrosine kinase activity (Zhu et al., 1995). ErbB2 
and erbB3 heterodimers are the most common at NMJs but do not appear to be necessary for 
NMJ formation (Gassmann et al., 1995; Lee et al., 1995; Meyer and Birchmeier, 1995; 
Riethmacher et al., 1997)  However, it appears that erbB2 is necessary for the observed 
increase in the expression of synaptic protein (Burden, 1998; Sanes and Lichtman, 1999; Leu, 
2003).  
NRG signaling through erbB receptors induces the expression of AChR transcription 
by activating the Ras/MAPK and PI3K pathways and activates the N-box promoter (Duclert 
and Changeux, 1995; Koike et al., 1995; Tansey et al., 1996; Altiok et al., 1997; Fromm and 
  19 
Burden, 1998).  Both of these signal transduction pathways appear to be necessary for the 
induction of AChR gene expression (Tansey et al., 1996; Altiok et al., 1997). Activation of 
ERK (a member of the MAPK pathway) promotes the binding of the heterodimer GA-
binding protein (GABP) ! and ", an Ets transcription factor, to the regulatory element 
termed N-box (Fromm and Burden, 1998; Schaeffer, 1998; Fromm and Burden, 2001). NRG 
can induce transcription in the absence of phosphorylated GABP!, suggesting GABP" or yet 
another molecule may be involved in this process more directly (Jaworski et al., 2007; 
Herndon and Fromm, 2008).  
The regulation of AChRs at the synapse by the N-box promoter is not unique. This 
binding domain is also found relative to, and as a regulatory element of, AChE, MuSK and 
erbB proteins (Lacazette et al., 2003). Interestingly, agrin has also been shown to activate the 
N-box regulatory sequence suggesting a convergence in pathways between agrin-MuSK and 
NRG-ErbB signaling pathways (Lacazette et al., 2003). As previously discussed, agrin 
signaling can also activate MAPK pathways which could lead to GABP activation. In 
addition MuSK expression at the synapse is regulated by the presence of an N-box in the 
musk promoter and regulated by agrin through the activation of c-Jun N-terminal kinase 
(JNK), which has been shown to phosphorylate GABP (Figure 5A). It has been suggested 
that erbB4 expressed by muscle could account for the activation of synapse specific genes, 
but little evidence has lead to this conclusion directly (Leu, 2003). 
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1.3.4 Neuregulin signaling may be dispensable for synapse formation 
Although initial studies suggested NRG to be a key factor in gene expression of synapse-
specific molecules, one study has shown otherwise. Yang and colleagues (2001) questioned 
the impact of NRG signaling on NMJ formation using HB9 mice and the cre-lox 
recombinase system, which selectively targets proteins in specific cell types, to generate and 
circumvent the lethality of complete KOs of agrin or neuregulin. In HB9 mutant mice the 
HB9 transcription factor has been inactivated, resulting in motor neurons that remain 
undifferentiated.  HB9 mutant mice do not have motor neurons innervating their muscle and 
as such there is no source of neural signals for synaptic differentiation. A conditional KO of 
MuSK in HB9 mutants demonstrates that although AChR expression is still present, no 
clustering is detected, suggesting that neuronal signals are dispensable for early patterning of 
AChRs and MuSK is responsible for patterning in the absence of motor innervation (Yang et 
al., 2001).  This study also suggests that AChR expression patterns do not change in the 
absence of agrin or NRG but do change for MuSK (Yang et al., 2001). It is possible that 
muscle agrin, shown to co-localize with MuSK and AChRs, initially clusters MuSK and then 
rapsyn activates MuSK, thus inducing the clustering and expression of these AChRs pre-
innervation (Yang et al., 2001) (Figure 5B).  Given these results, agrin, NRG and ACh 
signaling post-innervation would then refine and maintain aggregates, induces local sub-
synaptic expression of post-synaptic molecules, and inhibit the expression of extra-synaptic 
AChRs, respectively (Yang et al., 2001) (Figure 5A).  A role for NRG post-innervation was 
strengthened by the experiments of Jaworski et al., (2006).  Conditional inactivation of the 
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two cellular sources of NRG, specifically in motor neurons and muscle, revealed a normal 
pattern of synaptic molecule expression (Jaworski and Burden, 2006). Thus the strongest 
evidence is for agrin and agrin-MuSK signaling being primarily responsible for AChR 
patterning and expression and not NRG though this does not leave out a supportive role for 
NRG. 
 
1.3.5 Neuregulin-erbB4 has many roles in the CNS 
NRG, and its receptors, are highly expressed in the brain. NRG signaling in the CNS has 
been implicated in many important neurodevelopmental processes e.g. cell survival and 
migration, interneuronal synaptic stability, myelination, maturation of dendritic spines, 
synaptic plasticity and the regulation of acetylcholine and various neurotransmitter receptors 
such as AChR, GABAR, and GluR (Huang et al., 2000; Li, 2001; Liu et al., 2001; Mei and 
Xiong, 2008; Williams et al., 2008; Cui et al., 2013). Curiously, erbB4 is the least described 
but most predominant erbB receptor enriched in the post-synaptic densities of the brain 
(Garcia et al., 2000; Gerecke et al., 2001). NRG binds with high affinity to erbB4 and leads to 
the activation of the MAPK and PI3K pathways (Huang et al., 2000; Mei and Xiong, 2008). 
ErbB4 homodimerization does indeed form a functional receptor capable of signaling and 
leads to tyrosine phosphorylation in response to NRG stimulation (Carraway and Cantley, 
1994; Ma et al., 2003). This is achieved by the recruitment of erbB4, and adaptor proteins 
Grb2 and Shc, to neuronal lipid rafts where PSD-95 also co-localizes. Disruption of these 
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lipid raft signaling platforms inhibits NRG-induced ERK activation (Ma et al., 2003). The 
association of erbB4 with post-synaptic densities further supports its role in synaptic 
stability. The NRG-induced up-regulation of neurotransmitter receptor expression in the CNS 
is also analogous to what occurs at the NMJ. Thus far erbB4 has been demonstrated to be 
important in many diseases including schizophrenia, Alzheimer’s, amyotrophic lateral 
sclerosis (Chaudhury et al., 2003; Corfas et al., 2004; Takahashi et al., 2013). 
 
1.4 The regulation of inflammation by immune and nervous mechanisms 
1.4.1 Immune responses are divided  
Immune responses are categorized into innate, the first line of host defense, and adaptive (or 
acquired), those that include cell-mediated and humoral immunity. Innate immunity is 
mediated by antigen-presenting cells that recognize pathogen-associated molecular patterns 
(PAMPs) present on pathogens via a number of Toll-like receptors (TLR) that they express. 
Chemical signals secreted by antigen-presenting cells function to eliminate pathogens but 
also activate the differentiation of lymphocytes (T cells and B cells) signifying a transition 
from an innate to an adaptive immune response. Activated antigen-presenting cells undergo 
cytoskeletal reorganization and form immune antigen-specific synapses with naïve 
lymphocytes (Figure 1C) that become activated in the process (Pulecio et al., 2010). The 
adaptive immune response is characterized by antigen-specific lymphocytes reacting to an 
antigen and the development of immunological memory. These two responses are temporally 
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segregated though there is some overlap and antigen-presenting cells are important in the 
primary and secondary response (Santana and Esquivel-Guadarrama, 2006). Here I 
specifically focus on one of the primary and early responses of the innate immune system: 
inflammation. 
 
1.4.2 Inflammation is mediated by the innate immune system 
Inflammation is an immediate innate immune response designed to defend the body from 
pathogenic invasion. It activates antigen-presenting cells, recruits effector cells and contains 
infection until the initiating agent is removed. The signaling mechanisms underlying 
inflammatory responses are complex and involve numerous molecular players that have been 
extensively reviewed (please see (Beutler, 2000; Creagh and O'Neill, 2006; Foster and 
Medzhitov, 2009; Medzhitov, 2010; Arthur and Ley, 2013). Due to the comprehensive 
literature on the subject, here I present a simplified version of the typical inflammatory 
response. 
Bacterial products, such as lipopolysaccharride (LPS), cause local tissue macrophages 
to activate and drive the inflammatory response by producing an array of cytokines including 
tumor necrosis factor (TNF)-", interleukin (IL)-1!, IL-6 as well as other mediators  (Figure 
5A) (Kracht and Saklatvala, 2002; Fujihara et al., 2003). LPS, through the activation of 
TLR4, induces inflammation primarily by activating the transcription factor nuclear factor-
#B (NF-#B; Hayden and Ghosh, 2004). LPS, pro-inflammatory cytokines and chemokines 
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act locally, activating pre-existing macrophages in situ to produce vasodilators, vascular 
endothelial cells to express adhesion molecules and by recruiting circulating neutrophils and 
later monocytes, the precursors to macrophages, to the site of infection for pathogen 
elimination and subsequent antigen presentation to lymphocytes (Figure 6A).  
Adhesion molecules expressed on the surface of activated endothelial cells and 
increased vascular permeability allow for recruited leukocytes to “roll” over the endothelium, 
increasing and strengthening their interactions prior to migrating across the endothelial wall 
via extravasation (Vestweber, 2012). Extravasation occurs in four stages: rolling adhesion, 
tight binding, diapedesis and migration.  Enzymes, such as matrix metalloproteinases 
(MMPs), secreted by activated cells aid this process by loosening junctions and breaking 
down ECM proteins in the basement membrane (Sternlicht and Werb, 2001). Leukocytes that 
have migrated across the epithelium can phagocytose the infecting agent, process the antigen 
and express it on their cell surface. One exception to this rule is at the BBB. The CNS tightly 
regulates immune cell entry into the brain by the BBB, thus preventing systemic or 
peripheral immune cells and molecules from infiltrating the brain. The brain is in this sense 
an immune privileged site at which most immune responses are mediated by microglia, 
which are the primary immune cells and macrophages of the brain (Hickey, 2001; Nguyen et 
al., 2002; Streit et al., 2004; Engelhardt, 2006; Graeber et al., 2011; Muldoon et al., 2013).   
Inflammation is regulated via positive and negative feedback mechanisms. Pro-
inflammatory cytokines like TNF-" and IL-1! act via a positive feedback mechanism and if 
the infectious agent overwhelms the resident macrophages and number of effector cells 
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recruited, there is an over-production of these cytokines resulting in damaging effects. 
Surrounding cells, such as endothelial cells, are also sensitive to these cytokines and can 
become activated further perpetuating these effects. TNF-", IL-1! and IL-6 released 
systemically when the infection is no longer contained results in fever and acute phase 
response by acting on the hypothalamus, spleen and liver. Prolonged secretion of large 
amounts of TNF-" can be damaging and can potentially lead to septic shock and organ 
failure. Activated macrophages also produce the anti-inflammatory cytokine IL-10, which is 
a negative feedback regulator synthesized in homeostatic control of inflammation. IL-10 acts 
in an auto- and paracrine manner to inhibit the synthesis of pro-inflammatory cytokines, such 
as TNF-", as the infection is eliminated (Williams et al., 2004b).  Quite simply then, local 
inflammation is a balancing act seeking to clear infection while limiting the scope of the 
response and the extent of collateral damage. 
 
1.4.3 Acetylcholine regulates inflammation via the cholinergic anti-
inflammatory pathway 
Widespread inflammatory responses can be regulated by a neuro-immune axis termed the 
cholinergic or nicotinic anti-inflammatory pathway (Borovikova et al., 2000). The 
cholinergic anti-inflammatory pathway is a controlled mechanism that aims to keep localized 
inflammation from becoming systemic, thus preventing potentially lethal effects such as 
septic shock and organ failure (Ulloa, 2005). This bidirectional pathway is mediated by the 
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binding of ACh, synthesized by the efferent arm of vagus nerve, to the homopentameric 
!7nAChR present on macrophages and monocytes (Wang et al., 2003a).  
The activation of the !7nAChR by ACh initiates a signaling cascade that prevents the 
nuclear translocation of NF-#B and activation of the Jak2-STAT3 pathway (see figure 6B). 
This inhibits the production of pro-inflammatory cytokines such as TNF-" and IL-1! 
(Yoshikawa et al., 2006), but does not affect production of the anti-inflammatory cytokine 
IL-10 (Ulloa, 2005; Gallowitsch-Puerta and Pavlov, 2007).  
ACh also appears to control inflammation by affecting other effector cells involved in 
this innate immune response. Vascular endothelial cells also express the !7nAChRs and 
activation of this receptor in the presence of LPS inhibits the expression of cell adhesion 
molecules and the production of chemokines, which influence the recruitment and migration 
of leukocytes during inflammatory responses (Saeed et al., 2005). Collectively, it appears that 
ACh can mediate the inhibition of macrophage, monocyte, neutrophil and endothelial cell 
activation by LPS through the activation of the !7nAChRs. Due to the wide expression of 
AChRs in non-neuronal, non-excitatory cells (Wessler et al., 1998), where the ACh molecule 
acts more like a cytokine (autocrine/paracrine) than a neurotransmitter (paracrine) (Matthay 
and Ware, 2004), current research aims are to exploit the nicotinic anti-inflammatory 
pathway to treat autoimmune disorders (Pavlov and Tracey, 2006). Other inflammatory 
conditions such as periodontitis, psoriasis, sarcoidosis, ulcerative colitis, Crohn’s disease, 
and septic shock can also be targeted (Scott and Martin, 2006). However, there are cytotoxic 
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effects of therapeutically using nicotine, a high affinity agonist of the !7nAChR, as treatment 
for such disorders (Saeed et al., 2005). As such, there is an obvious need to investigate 
possible alternatives that can regulate inflammatory signaling pathways, perhaps upstream of 
!7nAChR activation. Determining how agrin and NRG are involved in regulating 
inflammation may provide for this alternative treatment. 
 
1.5 Agrin and NRG in the immune system 
Recent evidence suggests, roles for agrin and NRG in immune system function. Agrin and !-
DG (Mazzon et al., 2012), and !7nAChRs (Serobyan et al., 2007), have been individually 
described to be important in development of the hematopoietic system. Agrin and !-DG also 
appear essential to the survival of hematopoietic stem/progenitor cells (HSPC) that give rise 
to all hematopoietic cells which include monocytes, macrophages, neutrophils, T and B cells 
(Mazzon et al., 2012). Finally, agrin has been shown to regulate some immune cell functions 
on T lymphocytes (Khan et al., 2001; Jury et al., 2007; Kabouridis et al., 2012) and most 
recently on monocytes (Mazzon et al., 2012). These results identify agrin as an important 
molecule in development beyond the nervous system. 
In T lymphocytes, agrin has been implicated in regulating the threshold for 
lymphocyte activation by acting as a co-stimulatory molecule and reorganizing lipid rafts 
(Khan et al., 2001). Agrin appears to act in an autocrine/paracrine fashion in these cells 
(Khan et al., 2001), unlike at the NMJ and similar to ACh in non-neuronal tissues. Also, in 
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lymphocytes it appears that agrin’s clustering capability is not determined by an eight amino 
acid insert at the Z site, but rather by a deglycosylation event resulting from cellular 
activation.  Remarkably, this modification yields an active agrin molecule capable of 
clustering AChRs in muscle (Khan et al., 2001). This result also suggests that other agrin 
molecules, expressed in non-neuronal tissues, can induce cytoskeletal re-organization. Agrin 
signaling has been found to activate the MAPK pathway in T lymphocytes and augment IL-
10 production, though curiously it does not activate JNK or NF-#B (Jury et al., 2007).   In 
monocytes, agrin has been demonstrated to be necessary for cell survival and function, which 
is likely mediated by signaling through !-DG (Mazzon et al., 2012). Interestingly, agrin 
expressed on antigen-presenting cells, has also recently been implicated in 
multihistocompatability complex (MHC) clustering and antigen presentation, as well as 
augmenting the production of pro-inflammatory mediators (Kabouridis et al., 2012). This 
suggests an important regulatory role for agrin in immune cells. 
NRG/erbB4 signaling has been demonstrated to be involved in a variety of cellular 
and immune functions. Since NRG is highly expressed in glial cells, such as microglia, it is 
logical to investigate its roles in CNS immune regulation. Microglia are the macrophages of 
the CNS and are activated in response to physical and bacterial insult resulting in 
neuroinflammation, which is characterized by the synthesis of a variety of pro-inflammatory 
mediators. NRG has been reported to protect microglial cells against inflammation-induced 
cell death (Dimayuga et al., 2003) and appears to antagonize apoptosis by activating the PI3K 
pathway (Cui et al., 2013).  Recently, we have also implicated NRG in a neuroprotective role 
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on microglia.  NRG induced upregulation of !7nAChR on LPS-challenged microglia and 
lead to a significant decrease in pro-inflammatory mediators (Mencel et al., 2013). Not only 
does this suggest that NRG may augment the cholinergic anti-inflammatory pathway in 
microglia but this further supports claims of NRG’s involvement in neuroprotection in the 
CNS. 
  
1.6 Rationale and Objectives 
Although !7nAChRs have been implicated in the cholinergic anti-inflammatory pathway, 
and agrin and NRG have been described to be important for cell survival in the peripheral 
immune system and the brain respectively, the connection between agrin, NRG and AChRs 
has not been investigated. Using what we know about these molecules at nervous system 
synapses may provide insights into their role in the immune system. I have investigated roles 
for agrin and NRG in macrophages and microglia, respectively, and in inflammation as a 
whole.  Macrophages are one of the primary responders to infection and are essential to 
inflammatory processes in both the periphery and the brain. Inflammation is, on some level, 
at the forefront of an incredible number of chronic conditions and diseases. Since AChRs are 
ubiquitously expressed on all immune cells and mediate a cholinergic anti-inflammatory 
response initiated by ACh as part of a neuro-immune axis, neuron-derived molecules 
regulating immune responses are increasingly important. The major question is: Do these 
neurotrophic molecules play a similar role on macrophages as they do on muscle cells? Are 
they and their receptors expressed endogenously? And does this role affect inflammation as a 
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result of the augmentation of AChRs? Here I support the recently proposed notion that NRG 
and agrin are novel players in innate immunity. Treating immortalized microglial and 
macrophage cell lines with these neurotrophic molecules to determine their effect on the 
expression of AChRs as well as pro-inflammatory and anti-inflammatory cytokines has 
shown that both NRG and agrin can augment AChR and cytokine levels, in microglia and 
macrophages respectively. This gives insight into their possible role in innate immune 
response.  
Although it appears there is a difference in agrin and NRG function and a 
compensatory mechanism is prevalent, in the peripheral versus neuronal immune systems, 
respectively, both agrin and NRG are here implicated in mediating an anti-inflammatory 
response in concert with the cholinergic anti-inflammatory pathway. Here I will show that 
agrin treated macrophages express increased levels of endogenous agrin and !7nAChRs and 
cluster together on the cell surface, and that DG, !7nAChRs and endogenous agrin interact 
in macrophages. I will also show that agrin treated macrophages and neuregulin treated 
microglia, that have been challenged with LPS, exhibit decreased levels of pro-inflammatory 
cytokines and agrin can increase anti-inflammatory IL-10 in macrophages. In summary, agrin 
and NRG reduce mediators of inflammation, in concert with the cholinergic anti-
inflammatory pathway, in macrophages and microglia in vitro. 
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Chapter 2 
Materials and Methods 
2.1 Cell Lines and Culture 
The RAW264.7 murine macrophage cell line (TIB-71; ATCC) was cultured in RPMI 1640 
(Wisent, St. Bruno, QC) supplemented with 10% heat-inactivated fetal bovine serum (FBS; 
Wisent), 100IU/ml penicillin (Wisent) and 100mg/ml streptomycin (Wisent).  The BV-2 
murine microglial cell line (received as a gift from Dr. Michael J. Strong, University of 
Western Ontario, London, ON) was cultured in the same manner as the RAW264.7 cell line. 
The C2C12 murine myoblast cell line (CRL-1772; ATCC) was cultured in low glucose 
Dulbecco’s modified Eagle’s medium (DMEM; Wisent) supplemented with 10% FBS, 
100IU/ml penicillin and 100mg/ml streptomycin. When cells reached 80% confluency, 
culture media was changed to DMEM supplemented with 2% horse serum (HS; Wisent), 
100IUml penicillin and 100mg/ml streptomycin to allow for differentiation of myoblasts to 
myotubes. All cell lines were grown at 37 degrees Celsius and 5% CO2 with the exception of 
C2C12 cells which were grown at 8% CO2. 
E7 hybridoma cells were purchased from the Developmental Studies Hybridoma 
Bank (DSHB; University of Iowa, Iowa City, IA) for "-tubulin antibody production. E7 cells 
were grown in RPMI 1640 supplemented with 10% heat-inactivated FBS and 0.05mg/ml 
gentamycin. Cells remained in culture 10-14 days for efficient and maximum Ig secretion, 
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then the cells were centrifuged and discarded. Supernatant was retained, filter-sterilized and 
stored at 4 degrees Celsius until needed. 
 
2.2 Cell Culture Treatments 
Cells were cultured as described above in section 2.1, until approximately 80-90% 
confluency before treatments, and cell growth media was refreshed prior to treatments. 
Macrophages and microglia were either pre-treated for 5 or 30 minutes, respectively, with 
1mM pyridostigmine bromide (Sigma-Aldrich, St. Louis, MO), an acetylcholinesterase 
inhibitor, and 100µM acetylcholine chloride (ACh; Sigma-Aldrich) or left untreated [adapted 
from ((Borovikova et al., 2000; Wang et al., 2003a; Shytle et al., 2004)) to remain consistent 
with previous studies]. Then all macrophages were treated for four hours with 500pM agrin  
(rrC-Ag 3,4,8, R&D Systems, Minneapolis, MN), 100ng/ml lipopolysaccharide (LPS; 
Escherichia coli 0111:B4, Sigma-Aldrich, St. Louis, MO), both agrin and LPS, or left 
untreated, unless otherwise stated. All microglia were treated for four hours with either 1nM 
neuregulin (NRG; rh-NRG-1, Shenandoah Biotechnology, Warwick, PA), 100ng/ml LPS, 
both NRG and LPS, or left untreated, unless otherwise stated.  
 
2.3 Protein Extraction 
Following treatment of macrophages, cells were briefly washed twice with cold Dulbecco’s 
phosphate-buffered saline (D-PBS; Wisent), and harvested in D-PBS with a rubber 
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policeman.  Cells were then collected by centrifugation at 1500 rpm for 10 minutes at 4 
degrees Celsius. Supernatants were discarded and cell pellets were re-suspended and lysed in 
protein extraction buffer [25mM Tris-HCl pH 7.5, 25mM Glycine, 150mM NaCl, 1X 
Complete Protease Inhibitor Cocktail (Roche, Mississauga, ON), 1% Triton X-100 (Sigma-
Aldrich) and 5mM EDTA pH 8.0 (Quality Biological Inc., Gaithersburg, MD)] on ice for 15 
minutes. The supernatant was collected and centrifuged at 14000 rpm for 5 minutes at 4 
degrees Celsius.  
 
2.4 SDS-PAGE and Immunoblot Analyses 
Protein extracts were quantified using the Bio-Rad Protein Assay (Bio-Rad Laboratories, 
Mississauga, ON) for equal protein sample loading. SDS-PAGE and immunoblots were 
performed according to methods previously described (Jacobson et al., 1998). Protein 
samples were electrophoretically separated on 6, 8 or 10% SDS-PAGE, and subsequently 
transferred to a nitrocellulose membrane. Membranes were subjected to Ponseau S (Sigma-
Aldrich) stain to confirm efficient transfer of proteins then blocked overnight with either 5% 
non-fat dehydrated milk (NFDM) (for dystroglycan, agrin, and "-tubulin), 5% bovine serum 
albumin (BSA; Wisent) (for STAT3), or 2.5% BSA/2.5% NFDM (for !7nAChRs) in TBS-T 
[10mM Tris-HCl pH 7.5, 150 mM NaCl, 0.1% Tween 20]. Membranes were then incubated 
in primary monoclonal antibodies against agrin (1:1000, m247, m33; Cedarlane), !-DG 
(1:1000, 11H6; Millipore), "-DG (1:1000, NCL-b-DG; Leica Biosystems Newcastle, Ltd., 
Newcastle, UK), STAT3 (1:1000, Cell Signaling Technology, Inc., Danvers, MA), 
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polyclonal antibody against !7nAChR (1:1000, ab23832; Abcam, Cambridge, MA), and an 
e7 hybridoma-conditioned medium for loading control (1:250, "-tubulin; DSHB). 
Horseradish peroxidase (HRP)-conjugated secondary antibodies (1:1000-1:2000; 
Amersham, Arlington Heights, IL) were used to visualize protein-specific binding.  
Immunoreactivity was detected using ECL (Pierce, Rockford, IL) and captured on 
autoradiography film (LabScientific, Highlands, NJ). Molecular weight markers were used to 
estimate protein size (Fermentas, Burlington, ON). C2C12 protein extracts were used as a 
positive control for agrin and dystroglycan. For semi-quantitative analysis, the relative 
intensity of protein bands was determined by densitometry using NIH ImageJ software 
(NIH). 
 
2.5 Blocking experiments 
!-DG was blocked with the monoclonal antibody 11H6 (sc-53987; Santa Cruz 
Biotechnology, Santa Cruz, CA). This antibody was diluted 1:100 in cell culture medium one 
hour prior to treatments (adapted from (Jacobson et al., 1998)).  
 
2.6 Flourescent staining of !7nAChRs and co-staining of agrin for 
immunocytochemistry 
Cells were grown on etched glass coverslips overnight. Cells were treated as indicated in 
section 2.2. After treatment, 0.2µg/ml !-bungarotoxin-tetrarhodamine (!-BTX-Rho; T1175; 
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Life Technologies Inc., Burlington, ON) was added to cultures at room temperature for one 
hour to stain for !7nAChRs. Cells were washed twice with cold D-PBS and fixed with 4% 
paraformaldehyde (Sigma-Aldrich) prior to mounting onto glass slides Slowfade Gold 
mounting media (P36934; Life Technologies, Inc.).  
For co-staining of !7nAChRs and agrin, cells were first stained for !7nAChRs as 
indicated previously, washed and fixed with 2% paraformaldehyde (Sigma-Aldrich) to adjust 
for the permeabilization step. Cells were permeabilized with 0.3% Triton X-100/PBS and 
subsequently blocked with 10% HS/PBS. Cells were stained for agrin with a monoclonal 
antibody (1:200, m33; Cedarlane) diluted in 5%HS/PBS, overnight at 4 degrees Celsius, 
were washed in D-PBS, and then probed with a secondary antibody conjugated to FITC 
(1:200; Jackson Immunoresearch Laboratories, Inc., Westgrove, PA). Cells were then 
mounted onto glass slides with Slowfade Gold mounting media (Life Technologies, Inc.) 
prior to viewing.  
Slides were viewed and imaged using Zeiss Axiovert 200 microscope (Zeiss, 
Mississauga, ON), Qimaging retiga 1494 digital camera (Qimaging, Burnaby, BC), and 
Openlab software (Improvision, Waltham, MA), or Nikon Eclipse 90i fitted with a Nikon D-
eclipse C1 scan head using Nikon EZ-C1 software (Nikon Canada Inc., Mississauga, ON) for 
confocal microscopy, at a final magnification of 400x. Co-localization clusters were counted 
from a merged image of co-stained cells from at least 5 random fields using NIH ImageJ 
software (NIH, Bethesda, MD). Values are expressed per cell to take into account any 
difference in cell density between cultures. Clusters were counted independent of size. 
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2.7 Immunoprecipitation (IP) of !7nAChRs and co-IP of proteins 
!7nAChRs were immunoprecipitated from protein samples by incubation with 1µg biotin-
XX-!-bungarotoxin (Life Technologies) at 4 degrees Celsius for one hour with gentle 
rocking. Upon the addition of 50µl streptavidin-sepharose beads (Upstate Biotechnology, 
Lake Placid, NY), samples were incubated an additional hour at 4 degrees Celsius with 
gentle rocking.  
Similarly, agrin and dystroglycan were immunoprecipitated from protein samples 
using a monoclonal anti-agrin antibody (1 µg, m247 or m33; Cedarlane) and monoclonal 
11H6 anti-dystroglycan antibody (Santa Cruz), respectively, and 50µl recombinant protein-G 
agarose beads (Invitrogen).  
Beads were then washed with a high-salt IP wash buffer [50mM NaCl, Tris-HCl pH 
8.0, 0.5% Triton X-100] and reserved for western blot analysis.  
 
2.8 Analysis of secreted TNF-! , IL-6 and IL-10 by ELISA 
The concentration of secreted TNF-!, IL-6 and IL-10 in cell culture media was determined 
by ELISA, following the manufacturer’s protocol (88-7324, 88-7062, 88-7105; eBioscience, 
San Diego, CA). Cell culture media harvested from treated and untreated macrophages and 
microglial cells was stored at -80 degrees Celsius until needed. Cells were treated as 
previously indicated (see section 2.2). 
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2.9 Statistical Analyses 
All experiments were completed in triplicate or more and measurements are expressed as 
means ± SE, unless otherwise indicated. Statistical analysis was performed using Student’s t-
test to compare two groups. Statistical significance of differences between groups was 
analyzed by ANOVA with Tukey’s Post-Hoc test for multiple comparisons, unless otherwise 
indicated. Differences were considered significant when P values were less that 0.05, using 
Kaleidagraph 4.1.1 (Synergy Software, Reading, PA). 
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Chapter 3 
Results 
3.1 Agrin 
3.1.1 Agrin is expressed on macrophages and appears to be self-regulated 
Agrin expression has been previously described in a variety of neuronal and non-neuronal 
cells (Smith et al., 1987; Magill-Solc and McMahan, 1990) where it appears to mediate a 
significant number of cellular responses. In T cells, cell activation induces a deglycosylation 
event which increases the ability of endogenous agrin to aggregate receptors (Khan et al., 
2001). My initial investigations centered on whether agrin is endogenously expressed by 
macrophages and if it mediates the activation of macrophages as it does in T cells. To do this 
a functional macrophage cell line sensitive to LPS was utilized, RAW264.7, purchased from 
ATCC (Raschke et al., 1978). Initial, immunoblotting experiments with RAW264.7 extracts, 
indicated that agrin is endogenously expressed by the RAW264.7 murine macrophage cell 
line and that these cells are sensitive to exogenous agrin. The agrin in the RAW264.7 cell 
line is similarly expressed as that seen in the C2C12 murine myotube cell line (Figure 7). 
Whole cell extracts were prepared from the macrophage cell line RAW264.7 that were 
treated with 500pM agrin, 100ng/ml LPS or left untreated for four hours. Since agrin is 
secreted by all cholinergic neurons and to simulate this situation in vitro, cells were treated 
with a C-95 fragment agrin, described to be sufficient in mediating agrin’s activity 
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(Gesemann, 1995; Campagna and Fallon, 2006). Cells were also treated with LPS because it 
is a well-described and potent activator of macrophages and for the comparison of an 
activated phenotype (Beutler, 2000; Fujihara et al., 2003). A four hour incubation time was 
chosen based on previously described agrin activity on cultured muscle (Wallace, 1988) and 
because four hours is within a typical time frame for an innate immune response (Medzhitov, 
2007). Following electrophoretic separation and transfer to nitrocellulose, membranes were 
immunoblotted with a monoclonal antibody against agrin, m247, which binds close to the C-
terminal splice sites on agrin (Hoch et al., 1994). The core agrin protein has a molecular 
weight of approximately 200kDa. In untreated, agrin and LPS-treated RAW264.7 cells, agrin 
is differentially expressed as shown in a representative immunoblot (Figure 8A). The agrin 
endogenously expressed in macrophages is likely the transmembrane form, though the 
expression of a secreted form cannot be excluded (Khan et al., 2001). When compared to 
control (untreated) RAW264.7 cells, densitometric analyses conducted on unsaturated 
exposures from multiple immunoblots confirmed that agrin treatments induced 
approximately a 2.18±0.47–fold increase in endogenous agrin expression (n=5, Student’s t-
test p<0.001; Figure 8B). This increase is similar to what is observed in muscle in response 
to neural agrin (Lieth and Fallon, 1993). LPS addition did not appear to significantly induce 
an increase in agrin expression on macrophages (1.28±0.63-fold, n=5; Figure 8B). However, 
this result provides a possible baseline for agrin induction due to classical macrophage 
activation by LPS. The results documented here are in agreement to what occurs in muscle 
and suggest this non-neural agrin isoform is regulated in a manner similar to neural agrin 
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(Lieth and Fallon, 1993). These results also suggest that agrin activates macrophages, though 
it appears this response is separate from that seen upon LPS stimulation. The agrin-induced 
activation and induction may be autocrine in nature and self-regulatory. Unlike in T cells, no 
deglycosylation event, demonstrated by a differential immunoreactivity between m33 and 
m247 agrin antibodies on resting and activated cells (Khan et al., 2001), was observed in 
macrophages (unpublished observations). 
 To confirm the optimal concentration of agrin for treatments at four hours I tested a 
variety of doses on RAW264.7 cells as illustrated by the representative immunoblot shown in 
figure 9A. Using densitometric analysis, macrophages treated with 500pM agrin 
demonstrated the largest increase in endogenous agrin expression at 1.91±0.65 fold (n=3, 
p<0.05 ANOVA/ Fisher’s LSD p<0.05; Figure 9B) compared to control, an increase 
consistent with earlier experiments. Increases beyond this concentration were not as effective 
with 1000pM agrin yielding only a 1.78±0.13 fold increase (n=3, p<0.05 ANOVA/ Fisher’s 
LSD p<0.05) and 750pM agrin yielding a 1.73±0.50 fold in endogenous agrin expression. 
 
3.1.2 Agrin mediates its effects through DG in macrophages 
Agrin has been shown to bind DG in a variety of tissues (Gesemann et al., 1996; 1998). 
Initial experiments examined "-DG expression and demonstrated that "-DG is expressed in 
RAW264.7 cells, similar to that seen in C2C12 cells (Figure 10). The expression of "-DG 
indicates that !-DG must also be expressed as both !- and "-DG results from the post-
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translational cleavage of the same protein (Ibraghimov-Beskrovnaya et al., 1992). To 
determine if agrin mediates its inductive effects via DG an anti-!-DG monoclonal antibody 
was utilized to execute a !-DG blocking experiment (Gee et al., 1994; Jacobson et al., 1998). 
RAW264.7 cultures were subjected to treatment with a 1:100 dilution of the !-DG antibody 
11H6 for one hour prior to the addition of agrin, LPS, both agrin and LPS, or left untreated, 
for four hours. A representative immunoblot demonstrates that both agrin- or LPS-induced 
increases in the expression of endogenous agrin are significantly reduced by blocking !-DG 
(Figure 11A). Densitometric analysis indicated that blocking with 11H6 reduced the 
expression of endogenous agrin by 83% in agrin treated cells (n=3, p<0.0001 
ANOVA/Tukey HSD p<0.001) when compared to agrin treated alone (3.27±1.29 fold, n=3; 
Figure 11B). Interestingly, blocking with 11H6 also reduced the expression of endogenous 
agrin by 98.5% in cultures subsequently treated with LPS for 4 hours (n=3, p<0.0001 
ANOVA/Fisher’s LSD p<0.05) when compared to LPS treated alone (1.12±0.31 fold, n=3; 
Figure 4B). Taken together, these results suggest that agrin induction of endogenous agrin 
functions by binding to DG and this mediates agrin’s downstream effects. 
 
3.1.3 Agrin addition induces an increase in !7nAChR expression in 
macrophages 
At the NMJ, agrin signaling contributes to the increased expression of post-synaptic 
molecules, including AChRs (Jones et al., 1996; Yang et al., 2001; Lacazette et al., 2003). 
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!7nAChRs are expressed on macrophages and regulate inflammation (Wang et al., 2003a). 
To determine if agrin had similar inductive effects on macrophages I investigated the 
function of agrin on !7nAChR expression in RAW264.7 cells. Macrophages were either 
treated with agrin, LPS, or left untreated, for four hours. Preliminary experiments using crude 
protein lysates from RAW264.7 cells indicated a low level of expression of !7nAChR. To 
compensate for this !7nAChR was precipitated with !-BTX conjugated to biotin and 
streptavidin-agarose beads, and subsequently probed with !7nAChR anti-sera. A 
representative immunoblot illustrates that both agrin and LPS treatments induced an increase 
in !7nAChR expression (Figure 12A). Densitometric analysis revealed that agrin addition 
induced a 3.52±1.25 fold increase in !7nAChR expression in macrophages (n=3, p<0.05, 
Student’s t-test) while LPS only induced a non-significant increase of 1.40±0.38 fold (Figure 
12B). This data suggests that agrin induces !7nAChR expression and may function upstream 
of the cholinergic anti-inflammatory pathway. Whether LPS can induce an increase in 
protein expression of !7nAChRs has not been previously reported in macrophages in the 
periphery though experiments examining LPS challenged macrophages of the brain and 
!7nAChR expression remain inconclusive (Tyagi et al., 2010; Mencel et al., 2013). 
However, a LPS induced increase in !7nAChR mRNA has been reported in U937 
macrophages (Chernyavsky et al., 2010). Congruent with activation and taken with these 
observations, our results further implicate agrin in the activation of macrophages. 
  43 
3.1.4 ACh addition antagonizes agrin’s effects 
Nerve-secreted ACh activates a Cdk5 mechanism and reportedly antagonizes agrin’s effects, 
which results in the destabilization of AChR clusters at the NMJ (Lin et al., 2005; Misgeld et 
al., 2005). Since ACh has been implicated in mediating the cholinergic anti-inflammatory 
pathway in macrophages we then investigated if ACh would antagonize agrin’s effects in 
macrophages. To determine the effects of ACh, RAW264.7 cells were pre-treated with 
100µM ACh in the presence of an AChE inhibitor for five minutes, prior to treatment with 
agrin, LPS, both agrin and LPS, or left untreated, for four hours.  A representative 
immunoblot shows that ACh antagonizes the effects of both agrin and LPS on RAW264.7 
cells (Figure 13A). Densitometric analysis revealed that ACh pre-treated macrophages 
subjected to agrin addition reduced the expression of endogenous agrin by 94% when 
compared to agrin treated cells alone (2.13±0.11-fold, n=4, p<0.001 ANOVA/ Tukey’s HSD 
p<0.001; Figure 13B). Curiously, ACh also reduced the expression of endogenous agrin in 
LPS challenged macrophages by 67% when compared to LPS alone (1.31±0.25 fold, n=4, 
p<0.001 ANOVA/ Fisher’s LSD p<0.05; Figure 13B).  Experiments completed in muscle 
have described the antagonistic effects of ACh on agrin-induced clusters however there has 
been not report on the modulation of post-synaptic proteins. These results suggest an 
inhibitory or antagonistic role for ACh in macrophages with respect to agrin, in general. 
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3.1.5 Agrin addition clusters !7nAChRs on macrophages 
Nerve-derived agrin induces the aggregation of AChRs in the PNS and CNS (Reist et al., 
1992; Bowe et al., 1994). !7nAChRs have been reported to form clusters in macrophages 
(Wang et al., 2003a). Since our earlier results indicate that agrin may activate macrophages, 
similar to LPS, I next investigated if agrin induced the clustering of !7nAChRs in 
macrophages. To determine if agrin has a similar effect on macrophages RAW264.7 cultures 
were treated using 1nM agrin for maximum effect for four hours, or were left untreated, prior 
to staining with a rhodamine-conjugated !-BTX probe to allow for the visualization of 
!7nAChRs. Macrophages were then fixed and mounted under glass slides and subsequently 
visualized using fluorescent microscopy. A representative image qualitatively demonstrating 
an increase in the size and number of !7nAChR clusters observed as discrete puncta on agrin 
treated macrophages, compared to control, is shown in Figure 14A as indicated. !7nAChR 
clusters were counted per cell, independent of size, and are represented in figure 14B. Agrin 
induced a 2.74±0.30-fold increase in !7nAChR clusters (p<0.0001, Student’s t-test) in 
macrophage relative to the spontaneous clusters observed on untreated or control cells 
(Figure 14B). 
Spontaneous clusters observed in a small subset of untreated cells, especially at areas 
of cell-cell contact, were generally smaller than those observed in agrin-treated cells (<1µm 
in diameter). Agrin-induced clusters, however, are not much larger (~1-2µm in diameter) and 
thus would be considered microaggregates in muscle where agrin-induced aggregates are 
generally larger (>1µm in diameter and can be larger than 10µm; (Wallace, 1988). Overall, 
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these results indicate a role for agrin-induced clustering of surface !7nAChRs, and thus 
activation, in macrophages, and these results are in line with our previous results. 
 
3.1.6 Agrin expressed on macrophages co-localizes with !7nAChRs 
Nerve-derived agrin has been shown induce the clustering of various post-synaptic molecules 
including endogenous agrin (Lieth et al., 1992; Lieth and Fallon, 1993), and agrin receptors 
such as !-DG (Sugiyama et al., 1994), and AChRs have been shown to co-localize with both 
(Fallon and Gelfman, 1989; Gee et al., 1994; Sugiyama et al., 1994). The interaction and 
clustering of receptors is important in the initiation of a variety of signaling pathways. To 
determine if !7nAChRs also co-localize with agrin expressed on macrophages, RAW264.7 
cultures that were treated with 500pM agrin for four hours, or left untreated, were co-stained 
with rhodamine-conjugated !-BTX (red) for !7nAChRs and a primary monoclonal antibody 
against agrin followed by a FITC-conjugated secondary (green), respectively. Cells were 
visualized using confocal microscopy for improved resolution and representative images are 
shown in figure 15A. An artificial merge was used to visualize areas of co-localization 
between agrin and !7nAChRs (shown in yellow; Figure 15A). Our results again show an 
increase in the size and number of agrin-induced !7nAChRs clusters after four hours, 
compared to control, but also show that endogenous agrin expressed by macrophages also 
clusters on these in response to agrin in a similar manner. This observation is similar to what 
has been described at the NMJ, where muscle agrin clusters with 90% of AChRs (Lieth and 
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Fallon, 1993). Furthermore, agrin and !7nAChR co-localize in both treated and untreated 
macrophages (Figure 15A). The puncta observed in treated macrophages are more discrete 
and pronounced than in untreated cells (Figure 15A). Our results also indicate that there is a 
2.31±0.24-fold increase (Figure 15B, n=3, p<0.0001, Student’s t-test) in these surface 
clusters of !7nAChRs and agrin in agrin-treated macrophages. The existing puncta and few 
spontaneous clusters observed in untreated macrophages could be the result of endogenous 
agrin or pre-patterning events in these cells, similar to what occurs in muscle, as muscle agrin 
has low AChR clustering ability on its own (Godfrey, 1991; Lieth et al., 1992).  
To confirm that the co-localization observed with confocal microscopy was a result of 
a direct or indirect interaction between these molecules I used co-immunoprecipitation 
techniques to pull down endogenous agrin, !7nAChRs, and in addition agrin’s receptor !-
DG, from total protein lysates obtained from macrophages, prior to probing with agarose 
beads and separating the elutions via electrophoresis. Endogenous agrin interacting with 
!7nAChRs and !-DG on macrophages would suggest the involvement of agrin in a novel 
signaling complex mediating immune responses in these cells. Figure 16 demonstrates 
representative blots of experiments repeated three times. Total protein extracted from cells 
treated for four hours, or left untreated, were subjected to immunoprecipitation with either 
biotin-conjugated !-BTX, anti-!-DG or anti-agrin antibodies. These lysates were then pulled 
down with streptavidin-agarose or protein G beads prior to being electrophoretically 
separated. After transfer to nitrocellulose, membranes were immunoblotted with antibodies 
against agrin, !-DG, and !7nAChRs.  Our results confirm a direct interaction between all of 
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these molecules as demonstrated in Figure 16. Interestingly, our results suggest that the 
relative interaction between endogenous agrin and !7nAChRs in macrophages do not appear 
to differ amongst activated and unactivated macrophages, and this could suggest that 
macrophage activation in response to agrin does not directly initiate inflammatory pathways. 
We do see however, that there is an increased association of DG with agrin in 
immunoprecipitations completed with the m33 anti-agrin antibody, which is not seen with 
the m247 anti-agrin antibody, in extracts from agrin treated macrophages. The m33 antibody 
binds all isoforms of agrin and thus may associate better with !-DG. 
 
3.1.7 Agrin addition does not induce the synthesis of pro-inflammatory 
cytokines TNF-!  and IL-6 in macrophages 
Since !7nAChRs have been previously implicated in regulating inflammation via the 
cholinergic anti-inflammatory pathway (Borovikova et al., 2000; Wang et al., 2003a) and 
agrin has been shown to interact with and induce the expression of !7nAChRs (see above), I 
next investigated the impact of agrin on pro-inflammatory cytokine synthesis in 
macrophages. To determine if agrin affected the synthesis of TNF-!, one of the key local 
mediators of inflammation, in RAW264.7 cells, I used a commercially available ELISA kit 
for TNF-!. Culture media was harvested from RAW264.7 cells that were treated for four 
hours with agrin, LPS, both agrin and LPS, or left untreated, in the presence or absence of 
ACh. Figure 17 shows that a four hour treatment with agrin alone did not result in a 
significant increase in the concentration of TNF-! (14.82±0.70pg/ml) when compared to 
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LPS alone (401.82±7.39pg/ml, n=7, p<0.0001 ANOVA/Tukey HSD p<0.0001) relative to 
untreated controls (3.73±0.15pg/ml, n=7, p<0.0001 ANOVA/Tukey HSD p<0.0001). Agrin 
induced TNF-! levels were, in fact, comparable to those seen when macrophages were 
treated with ACh alone (13.30±2.86pg/ml, n=7; Figure 17). Agrin treated macrophages that 
have also been challenged with LPS (430.55±4.93pg/ml, n=7) exhibit TNF-! levels 
comparable to LPS alone, even in the presence of ACh (374.16±9.92pg/ml, n=7; Figure 17). 
These results taken together suggest agrin has no significant impact on the synthesis of the 
pro-inflammatory cytokine TNF-! in macrophages. 
 I then investigated the effect of agrin on IL-6 levels in macrophages, as IL-6 is 
another common pro-inflammatory mediator that functions locally but also has more 
systemic effects during inflammation. Using media collected from RAW264.7 cultures that 
had been treated for four hours with agrin, LPS, both agrin and LPS, or left untreated as a 
control, I analyzed the levels of secreted IL-6 using a commercially available ELISA kit. 
Figure 18 illustrates that agrin does not induce the synthesis of IL-6 in the absence (0pg/ml, 
n=3) or the presence of ACh (0 pg/ml, n=3), compared to control (0pg/ml, n=3). However, 
agrin added to LPS challenged macrophages induced a 56.8% decrease of IL-6 levels in the 
absence of ACh compared to LPS challenged alone (129.44±1.29pg/ml, n=3, p<0.0001 
ANOVA/ Fisher’s LSD p<0.05; Figure 18), and a 62.5% decrease of IL-6 levels in the 
presence of ACh compared to LPS challenged macrophages in the presence of ACh 
(242.87±5.93pg/ml, n=3, p<0.0001 ANOVA/ Fisher’s LSD p<0.05; Figure 18).  Recently, 
agrin has been implicated in the function and survival of monocytes (Mazzon et al., 2012). In 
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light of this recent study, the results presented suggest a primarily anti-inflammatory role for 
agrin. 
 
3.1.8 Agrin addition induces an increase in anti-inflammatory IL-10 synthesis 
in macrophages 
Over-expression of agrin in T cells of Lupus patients has been described to promote IL-10 
synthesis (Jury et al., 2007). IL-10 is a major regulator of anti-inflammatory gene synthesis. 
In light of our previous results and these recent findings I sought to determine if agrin 
affected the synthesis of IL-10 in macrophages. ACh functioning via !7nAChRs and 
cholinergic anti-inflammatory pathway has been described to not affect IL-10 synthesis 
(Borovikova et al., 2000). Using a commercially available ELISA kit for IL-10, I analyzed 
IL-10 levels in culture media harvested from RAW264.7 cells treated for four hours with 
agrin, LPS, both agrin and LPS, or untreated controls, in the absence and presence of ACh.  
Here I show that agrin alone induces a 15-fold increase in the concentration of IL-10 
(142.67±78.48pg/ml, n=4) compared to control (9.44±2.74pg/ml, n=4, p<0.05 ANOVA/ 
Fisher’s LSD p< 0.05; Figure 19). Interestingly, ACh appears to antagonize agrin’s effects as 
IL-10 levels are reduced by 92% in agrin treated macrophages in the presence of ACh 
(11.61±9.05pg/ml, n=4, p<0.05 ANOVA/ Fisher’s LSD p< 0.05; Figure 19) when compared 
to agrin treated alone. LPS has been previously reported to induce IL-10 synthesis in 
macrophages as part of a negative feedback loop and our results agree with this observation 
(199.48±41.46pg/ml, n=4, p<0.05 ANOVA/ Fisher’s LSD p< 0.001; Figure 19). Our results 
  50 
suggest that agrin may function upstream of IL-10 signaling pathways, directly and/or 
indirectly supporting the cholinergic anti-inflammatory pathway, by initiating survival 
pathways upon cell activation.   
 
3.1.9 Agrin addition induces an increase in the anti-inflammatory regulator 
STAT3 
Next I investigated how agrin might mediate its anti-inflammatory functions. One 
mechanism in which ACh acting through the cholinergic anti-inflammatory pathway 
mediates its anti-inflammatory functions is through the Jak2-STAT3 pathway (Marrero and 
Bencherif, 2009). STAT3 is a regulator of anti-inflammatory action and also responsible for 
activating the synthesis of IL-10 through a positive feedback loop and inhibition of LPS-
induced TNF-! and IL-6 synthesis by mediating the function of IL-10 (Williams et al., 
2004a). DG signaling has been reported to modulate STAT5 in some tissues (Leonoudakis et 
al., 2010). For these reasons it was very attractive to investigate agrin’s effect on STAT3. To 
determine if agrin regulates STAT3 activation in macrophages, RAW264.7 cells were either 
treated with agrin, LPS, both agrin and LPS, or left untreated, for 4 hours, prior to protein 
extraction. Upon electrophoretic separation of total protein lysates and immunoblotting with 
a monoclonal antibody against STAT3 I determined that agrin had no effect on STAT3 
protein levels at this time point (data not shown). However, macrophages treated with agrin, 
LPS, both agrin and LPS, or left untreated, for 15 minutes, did exhibit differential expression 
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of STAT3 as demonstrated by the representative immunoblot shown in Figure 20A. 
Densitometric analyses indicate that macrophages treated with agrin induced a 4.02±0.80-
fold increase in STAT3 expression (n=3, p<0.001 ANOVA/Tukey’s HSD p<0.05; Figure 
20B). In addition, treatment of macrophages with both agrin and LPS induced a 7.04±1.70-
fold increase in STAT3 expression (n=3, p<0.001 ANOVA/Tukey’s HSD p<0.05; Figure 
20B) suggesting an additive response. The increase in STAT3 in response to LPS is not 
surprising since LPS has been reported to induce IL-10 as a part of a negative feedback loop. 
This data suggests that agrin functions upstream of IL-10 synthesis and mediates an early 
event that increases STAT3 intracellularly and may promote cell survival. 
 
3.2 Neuregulin 
NRG (Calvo et al., 2010) and !7nAChRs (Hernandez et al., 2010) have been individually 
described to have neuroprotective roles in the CNS, though the two have not been 
investigated together. Previous work in our lab has shown that both microglia and 
macrophages expressed a functional erbB4 receptor, however treatments with NRG did not 
affect !7nAChR expression in RAW264.7 macrophages though receptor phosphorylation 
was observed (Mencel et al., 2013). An inductive effect on !7nAChR expression was only 
observed in BV-2 microglial cells, but agrin was unable to induce a significant increase in 
!7nAChR expression in microglia (Mencel et al., 2013). In line with !7nAChR’s role in the 
cholinergic anti-inflammatory pathway I continued to investigate the role of NRG in 
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modulating this pathway in microglia by examining the synthesis of pro-inflammatory 
mediators (Mencel et al., 2013). 
 
3.2.1 NRG addition results in a decrease of the pro-inflammatory cytokine TNF-
!  in the presence of ACh in microglia 
To investigate the effects of NRG on one of the key mediators of inflammation in microglia, 
TNF-!, I used a commercially available TNF-! kit to analyze media harvested from BV-2 
cells that had been pre-treated with 100µM ACh for 30 minutes prior to four hour treatments 
with 1nM NRG, 100ng/ml LPS, both NRG and LPS or left untreated. Similar to what was 
observed with macrophages, microglia treated with NRG did not exhibit an increased 
concentration in TNF-! when compared to untreated control (13.87±3.01pg/ml, n=7; Figure 
21). As expected, challenge with LPS lead to a significant increase in the concentration of 
TNF-! to 403.87±69.10pg/ml (n=7, Figure 21) in microglia compared to control. In cells 
treated with both NRG and LPS, a significant increase in TNF-! concentration was observed 
(338.48±64.64pg/ml, n=7; Figure 21), however this is likely directly the result of LPS 
addition. The addition of ACh to microglial cultures yielded the most interesting results. BV-
2 cells pre-treated with ACh and subsequently treated with NRG and LPS showed a reduced 
concentration of TNF-! by 32.76% to 287.80±47.69pg/ml when compared to ACh and LPS 
alone (428.02±70.24pg/ml, n=7, p<0.01, Student’s t-test; Figure 21). These results indicate 
  53 
that in the presence of ACh, NRG is a potent reducer of pro-inflammatory TNF-! (Mencel et 
al., 2013). 
 
3.2.2 NRG addition results in a decrease of the pro-inflammatory cytokine IL-6 
in the presence and/or absence of ACh in microglia 
Another pro-inflammatory mediator modulated by !7nAChR of the cholinergic anti-
inflammatory pathway is IL-6. As such, I next investigated the role of IL-6 in response to 
NRG addition to microglia. Using a commercially available IL-6 ELISA kit I analyzed media 
harvested from treated and untreated BV-2 cells in culture, in the same manner as for TNF-! 
(Figure 21). Similar to TNF-!, challenging microglia with LPS lead to an increase in IL-6 
concentration (12.37±0.12pg/ml, n=3) compared to control (0pg/ml, n=3; Figure 22). The 
addition of NRG alone did not induce an increase in the concentration of IL-6, also similar to 
TNF-!. Unlike what was observed with TNF-!, the addition of NRG to LPS challenged 
microglia did reduce the concentration of IL-6 secreted by 75.67% (3.01±0.12pg/ml) 
compared to LPS challenged alone (n=3, p<0.05 Student’s t-test; Figure 22). Furthermore, 
NRG’s effect on IL-6 synthesis is even more pronounced in microglia challenged with LPS 
in the presence of ACh. In this case, we see an 87.73% decrease in IL-6 between cells treated 
with ACh, NRG and LPS, 0.67±0.17pg/ml, compared to ACh and LPS alone, 
5.46±0.30pg/ml (n=3; Figure 22). Taken together with the results observed with NRG’s 
effects on TNF-!, these results further support an anti-inflammatory role for NRG in 
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microglia (Mencel et al., 2013). Curiously, NRG had no effect on IL-10 synthesis in 
microglia (data not shown), which could suggest that the pathways affected by NRG and 
agrin differ in microglia and macrophages, respectively. However, both NRG and agrin 
appear to function in concert with the cholinergic anti-inflammatory pathway in their 
respective systems.   
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Chapter 4 
Discussion 
A role for agrin in PNS and CNS synaptogenesis is well established. Within these systems 
agrin regulates the expression and clustering of AChRs for the efficient transmission of 
signals from cell-to-cell. Agrin expression in immune cells has been reported though a 
relationship between agrin and AChRs, like that seen in muscle cells, has not been previously 
investigated. In this study I report that exogenous neural agrin modulates endogenous agrin 
expression as well as the expression of !7nAChRs, and that agrin clusters with both, in 
macrophages. I also show that induced endogenous agrin expression is inhibited when !-DG 
is blocked, suggesting that agrin mediates some of its functions through !-DG. Within the 
immune system agrin may function by augmenting the cholinergic anti-inflammatory 
pathway through DG and mediate its anti-inflammatory support in a couple of ways. In 
addition to augmenting !7nAChRs, it appears to induce anti-inflammatory cytokine 
production possibly via the modulation of STAT3. Relatedly, I also demonstrate the 
regulation of inflammatory molecules by neuregulin. Building upon previous work 
completed by our lab where we show that neuregulin augments the expression of !7nAChRs 
on microglia, the phagocytic analogs of macrophages within the CNS (Mencel et al., 2013). 
Significantly I also show that NRG addition to microglia results in a dramatic decrease in 
pro-inflammatory cytokine synthesis (Mencel et al., 2013). 
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This research supports a role for agrin and neuregulin as novel players in innate 
immunity in the peripheral and neuronal immune systems, respectively, and potentially 
implicates both agrin and NRG in the cholinergic anti-inflammatory pathway. 
 
4.1 Neural agrin modulates endogenous agrin and !7nAChR expression 
in macrophages  
Agrin has been implicated in mediating cellular activation in immune cells by several 
research groups (Khan et al., 2001; Jury et al., 2007; Kabouridis et al., 2012). However, no 
connection has yet been identified between agrin and AChRs expressed on immune cells, 
though they have been examined individually (Wessler et al., 1998; 1999; Khan et al., 2001; 
Wessler et al., 2003; Jury et al., 2007; Neumann et al., 2007; De Rosa et al., 2009; Mazzon et 
al., 2011; Kabouridis et al., 2012; Mazzon et al., 2012). Agrin has been described in 
mediating cell activation in T cells (Khan et al., 2001; Jury et al., 2007; Kabouridis et al., 
2012) and survival in monocytes (Mazzon et al., 2012), while !7nAChRs have been 
demonstrated to also modulate cell activation.  In lymphocytes they appear to be part of the 
cholinergic anti-inflammatory pathway that inhibits cytokine synthesis and T cell 
proliferation. Related to this, the absence of !7nAChRs in T cells has been shown to 
suppress adaptive immunity (Westman et al., 2010). In macrophages, the cholinergic anti-
inflammatory pathway inhibits cell activation via !7nAChRs and can thus regulate 
inflammation. Given that agrin has an intricate relationship with AChRs in muscle, 
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regulating the expression of AChRs and contributing to the stability of AChR clusters at 
post-synaptic sites, and the significance of !7nAChRs in regulating inflammation, an 
examination of the relationship of these two molecules in immune cells could be noteworthy. 
Agrin is broadly and differentially expressed in various tissues. Upon the revelation 
that agrin is expressed in T cells (Khan et al., 2001), I was interested in determining if agrin 
was present in antigen presenting cells, in particular macrophages, like many other groups 
(Kabouridis et al., 2012; Mazzon et al., 2012). As it turned out, of peripheral blood 
mononuclear cells (PBMCs), agrin is predominantly expressed by the myeloid cell lineage 
that differentiates into monocytes/macrophages (Mazzon et al., 2012). Agrin expressed in T 
cells, has been reported to be in the transmembrane form and does not contain the Z insert 
site (Khan et al., 2001). In T cells, this isoform has been demonstrated to play a role in cell 
activation; it functions to decrease the threshold of activation by clustering T cell receptors 
(Khan et al., 2001). T cells are crucial to the development of adaptive immune responses and 
given the interplay between innate and adaptive immunity I wondered if agrin played a 
similar role in the development of innate responses and in antigen-presenting cells in 
particular.  Given this, I elected to investigate the function of agrin in macrophages.  
Macrophages are primary responders in the innate immune response and function to 
eradicate infection by the means of inflammation. Using an immortalized murine 
macrophage cell line RAW264.7 I showed that agrin is expressed in these cells (Figure 7). 
The agrin expressed here is likely the transmembrane form, though other isoforms cannot be 
excluded. In T cells, the addition of a truncated agrin isoform, termed neural agrin, induced 
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the activation of these cells. This induction was demonstrated by the deglycosylation of Tm-
agrin and the clustering of various receptors and molecules (Khan et al., 2001). Similarly, I 
looked for agrin induced cell activation in macrophages in conjunction with treatments with 
LPS, a potent activator of macrophages and inducer of inflammation, for a means of 
comparison. A significant induced increase in the expression of endogenous agrin in 
response to agrin but not LPS was observed independently (Figure 8). Furthermore, various 
concentrations of agrin can induce an increase in the expression of endogenous agrin in 
macrophages (Figure 9) mirroring it’s effects in muscle cells, where endogenous agrin 
expression is upregulated by the addition of neurally-derived agrin (Lieth and Fallon, 1993). 
These initial results raised some interesting questions about the role of agrin in inflammation, 
as we observed a different phenotype in endogenous agrin expression induced by a known 
inflammatory mediator, LPS, and by agrin. Curiously, agrin has been shown to induce 
capping of CD14, the co-receptor of TLR4 for LPS, and cluster MHC, involved in antigen 
presentation in macrophages, which would suggest a pro-inflammatory role for agrin 
(Kabouridis et al., 2012). However, we observed that longer treatments with agrin (24 hours) 
did not result in cell death, as exemplified by LPS treatment (Raschke et al., 1978). This 
agrees with a recent study that shows that agrin deficient macrophages are defective in 
mediating phagocytosis for pathogen eradication and exhibit enhanced apoptosis (Mazzon et 
al., 2012), suggesting a role for agrin in macrophage survival. In T cells, the addition of 
interferon (IFN) ! induces increased agrin expression with this expression coinciding with an 
increase in anti-inflammatory IL-10 synthesis (Jury et al., 2007). Finally, agrin was not 
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shown to activate NF-#B, which is an effector of LPS function that results in inflammation 
(Jury et al., 2007). Taken together these results do not support an inflammatory role for agrin 
and may in fact imply the contrary. 
The expression of !7nAChR on macrophages and their involvement in regulating 
inflammation (Wang et al., 2003a) lead us to investigate the relationship between agrin and 
!7nAChRs in these cells. Cholinergic neurons, such as the vagus nerve, regulate 
inflammation by secreting ACh that functions on various immune cells in the periphery, 
including macrophages (Borovikova et al., 2000). All cholinergic neurons secrete agrin as 
well, so it is not unlikely that neural agrin can mediate its effects on macrophages. Agrin 
signaling at the NMJ, through the convergence of multiple pathways, induces the expression 
of AChRs among other post-synaptic proteins (Lacazette et al., 2003). I demonstrated that 
agrin could also induce an increase in the expression of !7nAChRs in macrophages (Figure 
12). This suggests a regulatory role for agrin in inflammation by modulating the cholinergic 
anti-inflammatory pathway. The presence of AChRs is required for agrin-induced clustering 
of post-synaptic molecules in muscle (Marangi, 2001) and for the initiation of adaptive 
immune response in T cells (Westman et al., 2010). Agrin has been demonstrated to cluster 
various molecules on immune cells, however !7nAChR clustering has not been examined. In 
muscle, AChRs are required for the clustering of other post-synaptic molecules in response to 
agrin (Marangi, 2001). Our results demonstrate that agrin regulates !7nAChR clusters on 
macrophages (Figure 14). Furthermore, these clusters co-localize with endogenous agrin 
(Figure 15) and both agrin and !7nAChRs interact with the agrin receptor, !-DG (Figure 
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16). These events are analogous to what occurs in muscle where endogenously expressed 
agrin co-localizes with the majority of AChRs (Lieth and Fallon, 1993). The clustering of 
AChRs is thus crucial for efficient communication between cells, regardless of the type of 
cell. 
 
4.2 Possible mechanisms of agrin action in macrophages 
In macrophages, activation of NF-#B leads to inflammation by inducing synthesis of pro-
inflammatory cytokines such as TNF-!. Interestingly, the transcription factor NF-#B has 
been shown to regulate AChR clustering in muscle through increased rapsyn promoter 
activity resulting from the upregulation of RelA/p65 (Wang et al., 2010). As such NF-#B 
appears to play a role in the regulation of rapsyn expression. LPS and TNF-! are potent 
inducers of NF-#B activity and recently a number of neuronal factors have also been shown 
to activate this transcription though it appears that agrin does not activate NF-#B (Wang et 
al., 2010). We indirectly support that agrin does not activate NF-#B in macrophages as agrin 
does not appear to induce the synthesis of pro-inflammatory mediators in these cells (Figure 
17 and 18). It is possible that in macrophages, NF-#B also influences AChR clustering and 
through the rapsyn promotor modulates the expression of agrin. At this point it is unknown if 
rapsyn or a rapsyn-like protein is expressed in macrophages but if expressed it might explain 
the decreased expression of endogenous agrin induced by ACh (Figure 13) through the 
inhibition of NF-#B. Similar to in muscle, agrin signaling in these cells does not appear to 
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activate NF-#B, if the lack of TNF-! is indicative (Figure 17). It is possible that more than 
one pathway in macrophages regulates the clustering of AChRs. In muscle and macrophages, 
the ERK/MAPK pathway has been implicated in agrin signaling, though it has thus far been 
shown to have at least a minor, albeit negative role, in modulating clustering of AChRs in 
muscle (Rimer, 2010). In T cells the ERK pathway is activated by agrin cross-linking and 
leads to cytoskeletal re-organization, but stimulation with neural agrin directly has not been 
examined (Jury et al., 2007). The ERK/MAPK pathway makes for a likely candidate in 
mediating clustering in macrophages, but it is unclear if in these cells the effect would be 
positive or negative. In addition to this pathway, PI3K is also a strong candidate for being 
involved in mediating clustering events in macrophages. Agrin signaling has been shown to 
activate PI3K pathways in macrophages (Kabouridis et al., 2012) and muscle (Nizhynska et 
al., 2007) as well. Though PI3K is primarily reported in activating cell survival pathways, it 
has also been implicated in agrin-induced AChR clustering in muscle by regulating Rac and 
cdc42, involved in cytoskeletal re-organization (Nizhynska et al., 2007). Furthermore, PI3K 
inhibitors have the effect of inhibiting full-size AChR cluster formation by agrin and 
reducing AChR phosphorylation (Nizhynska et al., 2007).  
Several studies have proposed !-DG as the agrin receptor in immune cells (Zhang et 
al., 2006; Kabouridis et al., 2012; Mazzon et al., 2012). DG in muscle co-localizes with 
AChRs via rapsyn and has also been previously implicated in stabilizing AChR clusters 
(Apel et al., 1995). Interestingly, it has been recently proposed that agrin mediates survival 
signaling through !-DG, as !-DG has been shown to co-localize with Grb2 in monocytes 
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(Mazzon et al., 2012), as it does in muscle (Yang et al., 1995). In monocytes, signaling 
through !-DG activates PI3K signaling and blocked !-DG-agrin signaling enhances 
apoptosis in these cells (Mazzon et al., 2012). Similarly in muscle, disruption of !-DG 
signaling has been shown to disrupt PI3K signaling (Langenbach and Rando, 2002). Agrin 
has three major receptors in the CNS and the PNS: !3NKA, LRP4 and DG. These three 
receptors have been shown to be expressed in immune cells as well, with the highest 
proportion being !3NKA (Kabouridis et al., 2012). In light of the work completed by 
Mazzon and colleagues (2012), we investigated agrin-DG function. Agrin binds DG with 
great affinity at the NMJ (Bowe et al., 1994; Campanelli et al., 1994; Fallon and Hall, 1994; 
Gee et al., 1994; Sugiyama et al., 1994) and due to this affinity, DG seemed like a good 
candidate for an agrin receptor on macrophages that might mediate agrin’s functions. My 
results indicate that blocking the function of !-DG also inhibits an increase in endogenous 
agrin expressed in macrophages by neural agrin (Figure 11). Taken with previous work 
indicating that blocking !-DG also disrupts PI3K pathways (Mazzon et al., 2012) this further 
suggests !-DG as at least one immune regulatory receptor in macrophages through which 
agrin signaling may be self-regulatory. Other receptors for agrin cannot be excluded in 
playing a role in regulating inflammation in macrophages. Although both !3NKA and Lrp4 
have been described to be present on macrophages, no role has yet been determined 
(Kabouridis et al., 2012). In T cells, it has also been suggested that Tm-agrin may function as 
a receptor on its own (Jury et al., 2007). It is possible that this is also true in macrophages, 
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however my results only address endogenously expressed total agrin protein and it is unclear 
if the agrin expressed in these macrophages is Tm-agrin. Finally, the anti-!-DG antibody 
used in blocking experiments has an IgM heavy chain isotype, and thus is quite large. 
Because !-DG has been shown to co-localize with both endogenous agrin and !7nAChRs 
(Figure 16), it is possible that endogenous and !7nAChRs get blocked as well by this anti-!-
DG antibody.  
Curiously, blocking of DG in macrophages subsequently treated with LPS also 
yielded a similar phenotype to that seen with agrin (Figure 11). It is possible that DG and the 
LPS receptor, CD14, interact with each other and thus the blocking of DG also blocks CD14. 
This also could explain reports indicating that neual agrin induces capping of CD14 in 
PBMCs (Kabouridis et al., 2012). 
At the NMJ, ACh has a declustering and destabilizing effect on AChRs and tends to 
negate agrin’s effects via a Cdk5 mechanism (Lin et al., 2005; Misgeld et al., 2005). 
Stabilized clusters that are agrin-induced have a longer half-life on muscle than destabilized 
clusters, which are more likely to get internalized and recycled (Lin et al., 2005; Misgeld et 
al., 2005). This destabilizing effect is prominent in agrin isoforms lacking the Z insert 
(Misgeld et al., 2005). It is unknown if ACh would also counteract agrin-induced expression 
of endogenous agrin in muscle. However, this event is observed in macrophages that were 
subjected to treatment with ACh (Figure 13). ACh is considered to activate immune cells in a 
non-classical manner (De Rosa et al., 2009) and this ACh-induced cell activation does not 
induce an inflammatory response. Similarly, agrin-induced cell activation is not indicative of 
  64 
a pro-inflammatory phenotype as a result of surface receptor clustering. The initiated 
signaling pathway may converge with ACh initiated signaling pathways. Though early events 
appear antagonistic, they could still function in concert. A balance of events mediated by 
agrin and ACh may allow for proper immune response within a cell by achieving 
homeostasis with complex regulatory mechanisms that result in a similar purpose when 
confronted with inflammatory stimuli, namely anti-inflammatory regulation. 
 
4.3 Agrin may have a primarily anti-inflammatory role in macrophages 
The ability of agrin to induce endogenous agrin and !7nAChR expression suggests that agrin 
in macrophages may influence the cholinergic anti-inflammatory pathway that mediates the 
regulation of inflammation. The effect of agrin signaling in macrophages has recently been 
investigated with my results indicating a primarily anti-inflammatory role for agrin. Initial 
experiments examined the effect of agrin on pro-inflammatory cytokines TNF-! and IL-6 
synthesis in macrophages as these cytokines are directly and indirectly inhibited by the 
cholinergic anti-inflammatory pathway. I did not see an induction of the pro-inflammatory 
cytokine TNF-! (Figure 17) to any significant level after four hours in treatment with agrin 
when compared to LPS, which is a potent inducer of inflammatory cytokines. However, my 
results do indicate that agrin reduces IL-6 by 57% in LPS challenged macrophages (Figure 
18). Recently, Kabouridis and colleagues (2012) suggested a pro-inflammatory role for agrin 
in monocytes by examining TNF-! and IL-6. However, in this case, agrin only induced an 
increase in these cytokines in the presence of polyinosine-polycytidylic acid (poly-IC), which 
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activates a subgroup of TLRs (Kabouridis et al., 2012). The induction of TNF-! and IL-6 is, 
in that instance, likely the result of poly-IC itself (Kabouridis et al., 2012).  
The addition of agrin also augmented anti-inflammatory cytokine IL-10 secretion in 
RAW264.7 macrophages (Figure 19), indicated by a 15-fold increase in agrin-treated 
macrophages. This is in agreement with a study in Lupus T cells that demonstrated that over-
expression of agrin lead to augmented IL-10 expression (Jury et al., 2007). This is likely due 
to modulation of STAT3 expression by agrin (Figure 20). The Jak2-STAT3 pathway is one 
mechanism by which the cholinergic anti-inflammatory pathway functions (de Jonge et al., 
2005). STAT3 is an anti-inflammatory regulator that has been implicated in the inhibition of 
NF-#B-regulated pro-inflammatory cytokines and the synthesis of IL-10 via a positive 
feedback pathway. STAT3 can be activated through a few mechanisms: LPS-induced p38 
MAPK signaling, IL-10 receptor signaling, and ACh-induced Jak2 signaling. In monocytes, 
agrin has been reported to increase internal Ca2+ flux, transiently activating Akt/GSK3 of the 
PI3K pathway (Kabouridis et al., 2012). Interestingly, signaling through the PI3K-Akt-GSK3 
pathway has been implicated in suppressing inflammation by augmenting IL-10 inducible 
genes (Antoniv and Ivashkiv, 2011). Further supporting an anti-inflammatory role for agrin 
are experiments completed with agrin-deficient monocytes, which exhibit low survival and 
are defective in phagocytosis (Mazzon et al., 2012). Agrin has also been shown to signal 
through !-DG-Grb2 to activate ERK/MAPK pathways. It is unclear if agrin also activate 
p38! MAPK which has anti-inflammatory roles consistent with STAT3-IL-10 functions 
(Bode et al., 2012). Finally, IFN! has also been reported to induce agrin expression in T cells 
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(Jury et al., 2007) via STAT3 (Ziegler-Heitbrock et al., 2003). These results taken together 
support claims for agrin as a novel player in innate immunity. 
 
4.4 NRG fulfills similar roles to agrin in the neuronal immune system of 
the CNS 
Anticipating functional parallels, I also investigated potential roles for agrin and NRG on 
microglia, the macrophages of the CNS. The CNS is an immune privileged site in which the 
BBB separates its own immune system from the periphery. Previous work completed by our 
lab has indicated that microglia expressed erbB4 receptors and that they form  functional 
receptors in microglia capable of being phosphorylated by NRG (Mencel et al., 2013). NRG 
was also able to induce an increase in the expression of !7AChRs in microglia, however 
when NRG is added to macrophages we do not see a significant increase (Mencel et al., 
2013). Agrin addition to microglia had no significant effect on !7nAChR expression (data 
not shown). This suggests that agrin and NRG may have complementary roles in the 
peripheral and neuronal immune systems. Being that !7nAChRs are the most abundant form 
of acetylcholine receptors in the CNS, crucial to the cholinergic anti-inflammatory pathway, 
and NRG can regulate these receptors, we focused our attention on NRG-induced modulation 
of the pro-inflammatory cytokines TNF-! and IL-6 synthesis in microglia (Mencel et al., 
2013). Though we did not see NRG modulate IL-10, an anti-inflammatory cytokine, our 
results do indicate that NRG may play an anti-inflammatory role by reducing TNF-! and IL-
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6 levels. NRG reduced TNF-! levels in microglia challenged with LPS by 33%, though only 
in the presence of ACh (Figure 21). Additionally, NRG alone also reduced IL-6 levels in 
microglia challenged with LPS by 76% (Figure 22).  Taken together, these results imply an 
anti-inflammatory role for NRG on microglia, different from that seen with agrin on 
macrophages, wherein it inhibits pro-inflammatory cytokine synthesis. 
 
4.5 Agrin and NRG: Different functions, similar roles, in the periphery 
and the brain 
Inflammation is an essential part of the innate immune system, necessary for proper infection 
eradication and wound healing. The dysregulation of aspects of the inflammatory response is 
the basis of many chronic diseases. The augmentation of the cholinergic anti-inflammatory 
pathway and exploitation of the molecules of this system can potentially prevent some 
unnecessary damage that results from prolonged exposure to pro-inflammatory mediators. 
The modulation of !7nAChRs can thus be considered a therapeutic means of providing 
homeostasis to an unbalanced response and !7nAChR-mediated targets are already under 
investigation (Bencherif et al., 2011). Inflammation has been implicated in many chronic 
diseases, including (but not limited to) arthritis, Alzheimer’s, Chron’s, diabetes, 
atherosclerosis, psoriasis, asthma, cystic fibrosis, ulcerative colitis and cancer (Reviewed in 
Bencherif et al., 2011). In these diseases, agrin and NRG might prove to be new targets for 
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anti-inflammatory therapeutics. Agrin and NRG mediate survival pathways by augmenting 
the cholinergic anti-inflammatory pathway in their respective systems. 
Agrin demonstrates an anti-inflammatory role in macrophages and can function in 
concert with the cholinergic anti-inflammatory pathway in two ways: through early STAT3 
induction and later augmentation of !7nAChRs and anti-inflammatory IL-10. Though agrin 
does not work in concert with ACh, it could stabilize !7nAChR clusters necessary for 
mediating signal transduction from ACh and thereby potentiate the cholinergic anti-
inflammatory response.  
Similarly, in microglia, NRG augments !7nAChR expression and this coincides with 
a decrease in pro-inflammatory cytokines TNF-! and IL-6, thus also exhibiting an anti-
inflammatory role. Here, NRG appears to function in concert with ACh and ameliorates 
long-term effects of inflammation, though how this may be occurring needs further 
investigation. 
The results presented in this thesis offer a new perspective into the regulation of 
inflammation through the modulation of the cholinergic anti-inflammatory pathway. Here I 
implicate agrin and NRG as novel players in innate immune responses in the periphery and 
CNS capable of augmenting cytokine synthesis. Though agrin and NRG have slightly 
different functions in macrophages and microglia, respectively, the end result is the same: an 
anti-inflammatory one.  
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4.6 Future Directions 
It is evident from this work that agrin and NRG, two neurotrophic molecules, can function in 
innate immune response by promoting an anti-inflammatory phenotype in immune cells 
through the augmentation of components of the cholinergic anti-inflammatory pathway and 
cytokine synthesis. Although some insight into the roles of these molecules can be gained 
from previous studies completed in the PNS and CNS, still a lot of avenues need to be 
investigated into how these molecules function.  
One particular binding partner of interest and mediator of clustering of AChRs at the 
NMJ, mentioned in the discussion, is rapsyn. Thus far it is unknown whether rapsyn or a 
rapsyn-like molecule exists in immune cells, but because of the presence of DG and AChRs 
in these cells makes it a worthwhile molecule to investigate. Furthermore, a previous report 
has indicated that another agrin receptor, LRP4 is expressed in immune cells (Kabouridis et 
al., 2012). LRP4 is known to indirectly link AChRs through rapsyn at the NMJ thus making 
it a potentially interesting molecule to investigate. In particular, if present, how might agrin 
regulate its expression?  Does it bind to a MuSK-like receptor tyrosine kinase, and how 
might this receptor complex influence an immune response?  A MuSK-like protein could 
also regulate AChR phosphorylation providing an additional regulatory mechanism for the 
cholinergic anti-inflammatory pathway. 
In line with our previous work, the regulation of AChR synthesis in immune cells 
might also be an interesting avenue of investigation. Given that the PI3K pathway has been 
implicated in activating the N-box promotor in muscle, the regulation of a similar promotor, 
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perhaps an E-box promoter (for !-subunit AChRs, if present) or the presence of a rapsyn 
promoter would give further insight into just how agrin and NRG mediate their effects.  
Regardless of the particular focus, the results presented here have revealed new roles 
and research opportunities for agrin and NRG. The study of the function of these molecules 
in inflammation might hold the key to the amelioration of any number of inflammation-based 
diseases.  
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Figures 
 
Figure 1. Synapses in the PNS, CNS and immune system are a stable connection 
between cells.  
These junctions allow for efficient chemical communication and can evoke complex 
responses in participating cells. Synpases, regardless of the tissues involved, are very similar 
in structure and function. Pre-synaptic terminals contain synaptic vesicles containing 
chemical mediators. Cell adhesion molecules maintain contact and concentrate chemical 
mediators in the synaptic cleft, between cells, allowing for efficient communication. Post-
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synaptic terminals typically contain clustered receptors for the appropriate chemical 
messengers. Panel A shows a NMJ from the peripheral nervous system. The presynaptic 
terminal here is a motor neuron and the postsynaptic terminal is the muscle fiber. In the 
presynaptic terminal, synaptic vesicles contain the neurotransmitter acetylcholine. The 
postsynaptic terminal is a muscle fiber. (B) In the central nervous system, interneuronal 
synapses are prevalent and can be segregated into inhibitory (GABAergic) and excitatory 
synapses (glutamergic), which are dependent on the channels that are opened as the result of 
ligand binding to their specific receptors. Synaptic vesicles in the pre-synaptic terminal 
contain GABA in inhibitory synapses, which bind GABA-R in the post-synaptic terminal. 
Synaptic vesicles in the pre-synaptic terminal contain AMPA or NMDA in excitatory 
synapses, which bind glutamate receptors (Glu-R) in the post-synaptic terminal. Panel C 
depicts an immune synapse formed between an antigen-presenting cell (APC) and a T cell, 
but synapse between many types of immune cells can form. In this case, the antigen 
presented by the APC via its multihistocompatability complex (MHC) can create a response 
in the T cell, through its T cell receptor (TCR) that is antigen-specific. Synaptic vesicles 
contain cytokines that can function on either cell and thus the role of pre- or post-synaptic 
terminal is dynamic in immune synapses. 
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Figure 2. Agrin and its domains.  
This schematic representation of agrin depicts the sites of alternative splicing, structural 
domains, glycosylation sites and potential binding sites of important partners. Two isoforms 
of agrin are the result of alternative splicing at the N-terminus and these transmembrane and 
secreted forms of agrin can be further spliced at the Y and Z sites on the C-terminus of the 
agrin molecule. A 95 kDa fragment of agrin that spans from EGF1 to the C-terminus fully 
retains agrin’s clustering ability at the highest potency. Amino acid inserts at the Z site yield 
an ‘active’ agrin isoform, termed neural agrin, and that is essential for agrin-induced 
clustering of AChRs on myotubes. Muscle agrin is the result of an 4 or 0 amino acid insert at 
the Y site and neural agrin is the result of an 8 amino acid insert at the Z site.  
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Figure 3. A model of the agrin-MuSK complex at the NMJ.  
Agrin signaling through MuSK occurs through the binding of LRP4. MuSK is a receptor 
tyrosine kinase (RTK) where phosphorylation is mediated by adaptor proteins Dok7 and 
Tid1. Tid1 partially activates MuSK in the absence of agrin, and enhances the binding of 
LRP4 to agrin. Tid1 regulates the binding of Dok7 to MuSK and stabilizes AChR clusters 
through hsp70 and hsp90 bound to rapsyn. Rapsyn links AChRs to the actin cytoskeleton via 
!- and "-catenin. Rapsyn can also mediate the binding of DGC to AChRs (see Figure 4) 
though whether rapsyn can also link AChRs to the cytoskeleton has not been directly 
implied. Dvl and PAK also bind to MuSK and MuSK phosphorylation activates Tid1 and 
Dvl, which regulate Rho GTPases, Rac1/RhoA/cdc42 (not shown) and thus regulates AChR 
clustering.
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Figure 4. A simplified model of the dystroglycan complex (DGC) at the NMJ.  
This complex is part of a larger dystrophin-associated protein (DAP) complex present in 
muscle. In panel A, we see that the DGC is composed of !-dystroglycan (!-DG; peripheral 
membrane protein) and "-dystroglycan ("-DG; transmembrane protein). Agrin, laminin and 
perlecan are extracellular matrix protein able to bind !-DG. Dystrophin or utrophin (*), the 
homolog of dystrophin, bind to the C-terminus of "-DG and this connects the DGC to the 
cytoskeleton through the association of filamentous actin (F-actin). Although not considered 
part of the original complex we also show AChRs interacting with the DGC through rapsyn. 
Biglycan (extracellularly) and the signaling molecule Grb2 (intracellularly) also interact with 
"-DG. In panel B, we show possible downstream signaling pathways that have been 
associated with the DGC. These pathways may be mediated by Grb2 and include: MAPK, 
PI3K/AKT (survival) and Rac1/PAK1/JNK (cell growth and cytoskeletal reorganization). 
Molecules not shown here that also interact with the dystroglycan and considered part of the 
DAP complex include the membrane proteins sarcoglycan, sarcospan, and intracellular 
proteins dystrobrevin and syntrophin. 
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Figure 5. MuSK signaling is essential for post-synaptic specializations on muscle.  
Panel A shows that in the presence of innervation, neuronal signals that include agrin, 
neuregulin (NRG) and acetylcholine (ACh). NRG binding of erbB receptors and agrin 
binding of MuSK leads to phosphorylation of these receptors.  MuSK phosphorylation 
activates rapsyn and downstream signaling pathways include Rac and cdc42 (AChR 
clustering) and JNK. ErbB phosphorylations can activate PI3K and MAPK signaling 
pathways. Activation of MAPK signaling and JNK converge upon the activation of nuclear 
GA-binding protein (GABP) which binds an N-box promotor sequence and leads to the 
transcription of post-synaptic molecules: ErbB, MuSK and AChRs. In innervated muscle the 
AChR aggregates are more refined in synaptic regions and this can be attributed to muscle 
activity initiated by ACh, diminishing AChRs extra-synaptically (not shown). In panel B we 
see that in the absence of innervation MuSK phosphorylated by rapsyn can activate erbB and 
rapsyn sustaining the same pathways seen during innervation. Grey regions indicate original 
views regarding NRG and agrin co-operation that have been since challenged or considered 
dispensable for synaptogenesis.
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Figure 6. Inflammation is regulated via the cholinergic anti-inflammatory pathway in 
macrophages.  
In panel A, we see the canonical inflammatory response initiated by lipopolysaccharide 
(LPS) binding of Toll-like receptor 4 (TLR4) and CD14 via LPS-binding protein (LBP). 
Signaling through TLR4 recruits adaptor molecules (not shown) that lead to the activation of 
IKK complex, and inhibitory complex that then frees NF-#B for nuclear translocation and 
transcriptional activation of pro-inflammatory genes. NF-#B is responsible for the expression 
of immunoregulatory proteins that promote cell adhesion (VCAM and ICAM) and antigen 
presentation (MHC), pro-inflammatory cytokines that function in an autocrine/paracrine 
manner (TNF-!, IL-1, and IL-6), as well as apoptotic regulators (i.e. Bcl-XL).  TNF-! also 
further propogates this reaction by activating IKK through signaling of the tumor necrosis 
factor receptor (TNFR), thus sustaining an inflammatory response. In panel B we see the 
cholinergic anti-inflammatory pathway that is reliant on ACh secreted by the vagus nerve 
(not shown), which innervates the peripheral organs, such as the liver and spleen. These 
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organs are afflicted if localized inflammation turns systemic and leads to septic shock, which 
results in organ failure and fatality.   The efferent arm of the vagus nerve secretes 
acetylcholine in response to the presence of proinflammatory cytokines and endotoxins 
detected by the afferent arm of the vagus nerve (not shown). Endogenous acetylcholine, an 
agonist, binds the "7nAChR (AChR) present on macrophages, and inhibit the production and 
release of pro-inflammatory cytokines by two possible mechanisms, where activation of 
"7nAChR can 1) directly inhibit the nuclear translocation of NF-#B, and/or 2) initiate the 
Jak2/STAT3 pathway in which Jak2 is recruited to the "7nAChR, becomes phosphorylated 
and then phosphorylates STAT3. STAT3 dimerizes and is translocated to the nucleus and 
initiates transcription of anti-inflammatory genes.
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Figure 7. Agrin is endogenously expressed in the RAW264.7 macrophage cell line.  
A representative western blot for agrin in RAW264.7 macrophages (RAW) and C2C12 
myotubes (C2) demonstrates that agrin is expressed in macrophages, similar to muscle, 
although it appears to be less glycoslyated and not as highly expressed. Molecular mass 
markers are shown to the left in kDa.
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Figure 8. Agrin induces increased endogenous agrin expression in macrophages.  
A representative western blot for agrin in RAW264.7 cells following treatment with agrin (A; 
500pM) or LPS (L; 0.1µg/ml) over four hours is shown in panel A. Control cells were left 
untreated for four hours before extraction (C). Molecular mass markers are shown to the left 
in kDa. Expression levels of agrin were quantified via densitometry and are represented as 
averages (mean±SD) in panel B. Agrin induces the expression of endogenous agrin 
2.18±0.47-fold after four hours compared to basal levels observed in the untreated control 
**(n=5, Student’s t-test p<0.001). LPS addition resulted in 1.28±0.63-fold increase in 
endogenous agrin expression, though this is not significant. 
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Figure 9. Macrophages are responsive to various concentrations of agrin.  
RAW264.7 macrophage cells were treated for four hours with 1000pM, 750pM, 500pM and 
250pM of agrin, or left untreated (control). A representative western blot for endogenous 
agrin expression is shown in panel A. Molecular mass markers are shown to the left in kDa. 
Densitometric analysis of agrin expression is displayed in panel B and represents the 
averages from three trials (mean±SD). Treatment of macrophages with 500pM induces the 
highest level of endogenous agrin expression (1.91±0.65 fold, n=3), a value consistent with 
our earlier experiments *(p<0.05 ANOVA/Fisher’s LSD p<0.05).
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Figure 10. !-DG is expressed by RAW264.7 macrophages.  
A representative western blot for "-DG in RAW264.7 macrophages (RAW) and C2C12 
myotubes (C2) demonstrates that "-DG is expressed in macrophages, similar to muscle, 
although it appears to be not as highly expressed. The presence of "-DG indicates that !-DG 
must also be expressed, as they are the product of the same gene. Molecular mass markers 
are shown to the left in kDa.
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Figure 11. Blocking "-DG reduces the induction of endogenous agrin.  
A representative immunoblot for endogenous agrin expression in RAW264.7 cells is shown 
in panel A. Cells were blocked with 11H6 (DG) at a 1:100 dilution or left unblocked prior to 
treatment with either agrin (A), LPS (L), agrin and LPS (A+L), or left untreated as a control 
(C).  Endogenous agrin expression levels were quantified by densitometry and are presented 
as averages  (mean±SD) relative to the control lane (panel B). Antibody blocked samples 
reveal an 83% reduction in endogenous agrin in cells treated with agrin  **(n=3, p<0.0001 
ANOVA/Tukey’s HSD p<0.001 and 98% in cells treated with LPS *(n=3, p<0.0001 
ANOVA/Fisher’s LSD p<0.05).
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Figure 12. Agrin induces increased expression of "7nAChRs on macrophages.  
RAW264.7 cells were treated with agrin (A), LPS (L), or left untreated (C) for four hours 
prior to extraction and precipitation with !-BTX-biotin. A representative immunoblot for 
!7nAChR expression is shown in panel A. Molecular mass markers are shown on the left in 
kDa. Densitometry was subsequently utilized for analysis of multiple blots and the values 
presented in panel B are the means±SD of agrin or LPS induction of !7nAChR compared to 
control. Agrin treated macrophages show a significant 3.52±1.25 fold increase in !7nAChR 
expression when compared to our control values *(n=3, p<0.05, Student’s t-test).
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Figure 13. Acetylcholine negates agrin’s effects on the induction of endogenous agrin. 
RAW264.7 macrophages were treated with agrin (A), LPS (L), agrin and LPS (A+L), or left 
untreated (C), in the presence or absence of acetylcholine (ACH). A representative western 
blot for endogenous agrin expression is shown in panel A. Molecular mass markers are 
displayed in kDa on the left. Densitometric analysis of endogenous agrin expression is 
represented as averages (mean±SD) compared to control (panel B). Acetylcholine pre-
treatment reduced agrin expression in agrin treated macrophages by 94% **(n=4, p<0.001 
ANOVA/Tukey’s HSD p<0.001) and in LPS treated cells by 67% *(n=4, p<0.001 
ANOVA/Fisher’s LSD p<0.05) compared to the control.  
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Figure 14. Agrin induces clustering of surface !7nAChRs on macrophages.  
RAW264.7 cells were either treated with agrin (1nM) or left untreated for four hours.   Following treatment, cells were incubated with 
rhodamine-conjugated !-bungarotoxin (BTX-Rho) for one hour, washed then fixed with 4% paraformaldehyde. !7nAChR aggregates 
can clearly be seen on the agrin treated cells (above, right, panel A). Scale bar is 10µm. In panel B, agrin-induced !7nAChR clusters 
were quantified relative to spontaneous clusters observed in control cells and are represented as average # of clusters/cell (means±SE). 
Counts were obtained from at least 5 fields. All AChR clusters were counted, independent of size. Agrin treated macrophages 
demonstrate a 2.74±0.30 fold increase in !7nAChR clusters ***(p<0.0001, Student’s t-test).
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Figure 15. Tm-agrin and !7nAChRs co-localize on macrophages.  
RAW264.7 macrophages were either treated with agrin (500pM) or left untreated for four hours. Following treatment cells were 
incubated with BTX-Rho (red) to stain for !7nAChRs for one hour, washed then fixed with 2% paraformaldehyde. Cells were then 
permeabilized and incubated with monoclonal antibody m33 against agrin, followed by a FITC antibody (green). Fluorescent images 
were obtained using confocal microscopy and an artificial merge (yellow) was used to show co-localizations (panel A). Increased co-
localization is visible in agrin treated cells (bottom, right, panel A). Scale bar is 20 µm. In panel B, cells showing distinct clusters of 
co-localization were counted, quantified, and represented as average # of clusters/cell (means±SE). Counts were obtained from at least 
5 fields. Agrin treated macrophages demonstrate a 2.31±0.24 fold increase in co-localizations ***(p<0.0001, Student’s t-test).
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Figure 16. Agrin and !7nAChRs directly interact with the agrin receptor, !-DG.  
Total cell extracts obtained from RAW264.7 cells left untreated (C), treated with agrin (A), LPS (L), or agrin and LPS (A+L) for four 
hours, were subjected to immunoprecipitation with BTX-biotin and streptavidin-agarose beads (panel A), anti-!-DG antibody and 
protein-G beads (panel B), or anti-agrin m33 antibody and protein-G beads (panel C). A representative western blot demonstrating co-
immunoprecipitations of !7nAChRs, !-DG and agrin are shown. Arrows indicate proteins that were probed with antibodies against 
agrin, !-DG, and !7nAChRs. Immunoblots show that !7nAChRs co-immunoprecipitate with agrin and !-DG (panel A), !-DG co-
immunoprecipitates with agrin and !7nAChR (panel B), and agrin co-immunoprecipitates with !-DG and !7nAChR (panel C), in all 
treatments compared to control. 
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Figure 17.  Agrin does not affect TNF-! synthesis in macrophages.  
Media from cultures left untreated (C), or treated with agrin (A), LPS (L), or agrin and LPS 
(A+L), in the presence or absence of ACh (ACH), for four hours, was analyzed for TNF-! 
concentrations using a commercially available ELISA kit. TNF-! levels induced by agrin 
(14.82±0.70pg/ml, n=7) were minimal and comparable to those induced by ACh 
(13.30±2.86pg/ml, n=7). These levels are not comparable to the induction of increased TNF-
! levels observed in cells challenged with LPS in the absence of ACh 
***(401.82±7.39pg/ml, n=7, p<0.0001 ANOVA/Tukey’s HSD p<0.0001). 
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Figure 18. Agrin treatment inhibits IL-6 synthesis in macrophages.  
RAW264.7 culture media from untreated (C), agrin treated (A), LPS (L), or agrin and LPS 
(A+L) treated cells, in the presence or absence of ACh (ACH), was analyzed for IL-6 
expression using a commercially available ELISA kit. IL-6 levels decreased by 57% in agrin 
and LPS treated cells when compared to LPS treated cells alone *(n=3, p<0.0001 
ANOVA/Fisher’s LSD p<0.05). However, in the presence of ACh, agrin reduced IL-6 levels 
by 62% in LPS challenged cells compared to LPS in the presence of ACh *(n=3, p<0.0001 
ANOVA/Fisher’s LSD p<0.05). Thus, agrin in the presence or absence of ACh did reduced 
IL-6 levels in macrophages.
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Figure 19. Agrin increases the synthesis of anti-inflammatory IL-10 in macrophages.  
RAW264.7 culture media from untreated (C), agrin (A), LPS (L), agrin and LPS (A+L), 
treated cells in the presence or absence of ACh (ACH), was analyzed for IL-10 
concentrations using a commercially available ELISA kit. IL-10 levels were increased 15-
fold *(142.67±78.48pg/ml, n=4, p<0.05 ANOVA/Fisher’s LSD p<0.05) in agrin treated 
macrophages compared to untreated. RAW264.7 cultures pre-treated with ACh and 
subsequently treated with agrin reduces IL-10 levels by 92% *(11.61±9.05pg/ml, n=4, 
p<0.05 ANOVA/Fisher’s LSD p<0.05) compared to agrin treated alone.
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Figure 20. Agrin induces an increase in immunoregulatory STAT3 in macrophages.  
A representative western blot for STAT3 in RAW264.7 cells treated with agrin (A), LPS (L), 
or left untreated (C) for 15 minutes is shown in panel A. Molecular mass markers are shown 
on the left in kDa. Values obtained by densitometric analysis are represented in panel B 
represent the means±SD relative to control. Agrin treated macrophages show a 4.02±0.80-
fold increase in STAT3 expression *(n=3, p<0.001 ANOVA/Tukey’s HSD p<0.05) 
compared to control. Agrin treated macrophages that have been LPS challenged induced a 
7.04±1.70-fold increase in STAT3 expression *(n=3, p<0.001 ANOVA/Tukey’s HSD 
p<0.05) relative to control.
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Figure 21. NRG in the presence of ACh reduces the secreted levels of TNF-! in LPS 
challenged microglia.  
Media from BV-2 cultures left untreated (C), or treated with 1nM NRG (N), LPS (L), NRG 
and LPS (A+L), in the presence or absence of ACh (ACH), for four hours, was analyzed for 
TNF-! concentrations using a commercially available ELISA kit. TNF-! levels decreased by 
16% in LPS challenged microglia treated with NRG compared to LPS treated alone 
(403.87±69.10pg/ml, n=7). In the presence of ACh, NRG reduced TNF-! by 33% in 
microglia challenged with LPS *(n=7, p<0.01, Student’s t-test).
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Figure 22. NRG reduces secreted IL-6 levels in the presence or absence of ACh in 
microglia challenged with LPS.  
Media from BV-2 cultures left untreated (C), or treated with NRG (N), LPS (L), NRG and 
LPS (A+L), in the presence or absence of ACh (ACH), for four hours, was analyzed for IL-6 
concentrations using a commercially available ELISA kit. IL-6 levels decreased by 76% in 
LPS challenged microglia treated with NRG *(n=3, p<0.05, Student’s t-test) compared to 
LPS challenged alone. In the presence of ACh, IL-6 levels decreased by 88% in LPS 
challenged microglia treated with NRG *(n=3, p<0.05, Student’s t-test) compared to LPS 
challenged microglia in the presence of ACh alone.
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